MOOG INC.
For the period ended Sep 27, 2025. Filed Nov 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Nov 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Item 8. | Financial Statements and Supplementary Data. |
|---|
| Fiscal Years Ended | |||
|---|---|---|---|
| (dollars in thousands, except share and per share data) | September 27, 2025 | September 28, 2024 | September 30, 2023 |
| Net sales | $3,860,624 | $3,608,960 | $3,316,190 |
| Cost of sales | 2,794,802 | 2,589,525 | 2,414,090 |
| Inventory write-down | 8,474 | 7,027 | 4,345 |
| Gross profit | 1,057,348 | 1,012,408 | 897,755 |
| Research and development | 93,671 | 112,773 | 106,551 |
| Selling, general and administrative | 553,968 | 501,253 | 474,937 |
| Interest | 72,075 | 66,330 | 59,838 |
| Asset impairment and fair value adjustment | 5,374 | 22,149 | 14,628 |
| Restructuring | 10,015 | 23,788 | 7,997 |
| Loss on sale of businesses | — | — | 900 |
| Gain on sale of buildings | — | (979) | (10,030) |
| Pension settlement | — | — | 12,542 |
| Other | 9,597 | 17,348 | 8,872 |
| Earnings before income taxes | 312,648 | 269,746 | 221,520 |
| Income taxes | 77,620 | 60,960 | 46,364 |
| Net earnings | $235,028 | $208,786 | $175,156 |
| Net earnings per share | |||
| Basic | $7.42 | $6.53 | $5.50 |
| Diluted | $7.33 | $6.45 | $5.47 |
| Weighted average common shares outstanding | |||
| Basic | 31,680,280 | 31,954,689 | 31,831,687 |
| Diluted | 32,082,601 | 32,359,338 | 32,044,226 |
| Fiscal Years Ended | |||
|---|---|---|---|
| (dollars in thousands) | September 27,2025 | September 28,2024 | September 30,2023 |
| Net earnings | $235,028 | $208,786 | $175,156 |
| Other comprehensive income (loss) ("OCI"), net of tax: | |||
| Foreign currency translation adjustment | 20,908 | 44,955 | 41,547 |
| Retirement liability adjustment | 23,978 | 6,315 | 11,626 |
| Change in accumulated gain (loss) on derivatives | 207 | 518 | 3,269 |
| Other comprehensive income (loss), net of tax | 45,093 | 51,788 | 56,442 |
| Comprehensive income | $280,121 | $260,574 | $231,598 |
| (dollars in thousands, except per share data) | September 27, 2025 | September 28, 2024 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $62,013 | $61,694 |
| Restricted cash | 200 | 123 |
| Receivables, net | 506,768 | 419,971 |
| Unbilled receivables | 744,352 | 690,572 |
| Inventories, net | 914,302 | 862,541 |
| Prepaid expenses and other current assets | 142,345 | 87,745 |
| Total current assets | 2,369,980 | 2,122,646 |
| Property, plant and equipment, net | 1,019,906 | 928,588 |
| Operating lease right-of-use assets | 52,799 | 52,591 |
| Goodwill | 842,313 | 833,764 |
| Intangible assets, net | 66,101 | 63,479 |
| Deferred income taxes | 22,459 | 23,884 |
| Other assets | 52,497 | 52,695 |
| Total assets | $4,426,055 | $4,077,647 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Current installments of long-term debt | $1,563 | $— |
| Accounts payable | 318,402 | 293,888 |
| Accrued compensation | 106,040 | 104,027 |
| Contract advances and progress billings | 372,988 | 302,126 |
| Accrued liabilities and other | 320,075 | 313,373 |
| Total current liabilities | 1,119,068 | 1,013,414 |
| Long-term debt, excluding current installments | 944,123 | 874,139 |
| Long-term pension and retirement obligations | 157,218 | 167,161 |
| Deferred income taxes | 32,600 | 27,652 |
| Other long-term liabilities | 180,491 | 166,464 |
| Total liabilities | 2,433,500 | 2,248,830 |
| Shareholders’ equity | ||
| Class A - Authorized 100,000,000 shares | 43,864 | 43,835 |
| Class B - Authorized 20,000,000 shares. Convertible to Class A on a one-for-one basis | 7,416 | 7,445 |
| Additional paid-in capital | 839,328 | 784,509 |
| Retained earnings | 2,834,548 | 2,635,950 |
| Treasury shares | (1,209,200) | (1,082,240) |
| Stock Employee Compensation Trust | (195,491) | (194,049) |
| Supplemental Retirement Plan Trust | (170,191) | (163,821) |
| Accumulated other comprehensive loss | (157,719) | (202,812) |
| Total shareholders’ equity | 1,992,555 | 1,828,817 |
| Total liabilities and shareholders’ equity | $4,426,055 | $4,077,647 |
Consolidated Statements of Shareholders’ Equity
| Fiscal Years Ended | |||
|---|---|---|---|
| (dollars in thousands) | September 27, 2025 | September 28, 2024 | September 30, 2023 |
| COMMON STOCK | |||
| Beginning and end of year | $51,280 | $51,280 | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | |||
| Beginning of year | 784,509 | 608,270 | 516,123 |
| Issuance of treasury shares | 30,614 | 8,572 | 7,852 |
| Equity-based compensation expense | 12,714 | 11,737 | 8,119 |
| Adjustment to market - SECT and SERP | 11,491 | 155,930 | 76,176 |
| End of year | 839,328 | 784,509 | 608,270 |
| RETAINED EARNINGS | |||
| Beginning of year | 2,635,950 | 2,462,640 | 2,321,558 |
| Net earnings | 235,028 | 208,786 | 175,156 |
| Dividends (1) | (36,430) | (35,476) | (34,074) |
| End of year | 2,834,548 | 2,635,950 | 2,462,640 |
| TREASURY SHARES AT COST | |||
| Beginning of year | (1,082,240) | (1,057,938) | (1,047,012) |
| Class A and B shares issued related to compensation and acquisitions | 15,537 | 12,436 | 16,107 |
| Class A and B shares purchased | (142,497) | (36,738) | (27,033) |
| End of year | (1,209,200) | (1,082,240) | (1,057,938) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | |||
| Beginning of year | (194,049) | (114,769) | (73,602) |
| Issuance of shares | 32,664 | 28,202 | 15,713 |
| Purchase of shares | (28,985) | (22,247) | (14,841) |
| Adjustment to market | (5,121) | (85,235) | (42,039) |
| End of year | (195,491) | (194,049) | (114,769) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | |||
| Beginning of year | (163,821) | (93,126) | (58,989) |
| Adjustment to market | (6,370) | (70,695) | (34,137) |
| End of year | (170,191) | (163,821) | (93,126) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | |||
| Beginning of year | (202,812) | (254,600) | (311,042) |
| Other comprehensive income (loss) | 45,093 | 51,788 | 56,442 |
| End of year | (157,719) | (202,812) | (254,600) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,992,555 | $1,828,817 | $1,601,757 |
(1)Cash dividends were $1.15, $1.11 and $1.07 per share for the fiscal years ended September 27, 2025, September 28, 2024, and September 30, 2023, respectively.
Consolidated Statements of Shareholders’ Equity, Shares
| Fiscal Years Ended | |||
|---|---|---|---|
| (share data) | September 27, 2025 | September 28, 2024 | September 30, 2023 |
| COMMON STOCK - CLASS A | |||
| Beginning of year | 43,835,149 | 43,822,344 | 43,806,835 |
| Conversion of Class B to Class A | 28,309 | 12,805 | 15,509 |
| End of year | 43,863,458 | 43,835,149 | 43,822,344 |
| COMMON STOCK - CLASS B | |||
| Beginning of year | 7,444,564 | 7,457,369 | 7,472,878 |
| Conversion of Class B to Class A | (28,309) | (12,805) | (15,509) |
| End of year | 7,416,255 | 7,444,564 | 7,457,369 |
| TREASURY SHARES - CLASS A COMMON STOCK | |||
| Beginning of year | (14,633,512) | (14,657,897) | (14,614,444) |
| Class A shares issued related to compensation and acquisitions | 136,092 | 44,658 | 50,057 |
| Class A shares purchased | (516,037) | (20,273) | (93,510) |
| End of year | (15,013,457) | (14,633,512) | (14,657,897) |
| TREASURY SHARES - CLASS B COMMON STOCK | |||
| Beginning of year | (2,861,088) | (2,896,845) | (3,020,291) |
| Class B shares issued related to compensation | 245,499 | 254,853 | 336,451 |
| Class B shares purchased | (210,400) | (219,096) | (213,005) |
| End of year | (2,825,989) | (2,861,088) | (2,896,845) |
| SECT - CLASS A COMMON STOCK | |||
| Beginning and end of year | (425,148) | (425,148) | (425,148) |
| SECT - CLASS B COMMON STOCK | |||
| Beginning of year | (548,084) | (592,128) | (611,942) |
| Issuance of shares | 170,034 | 183,403 | 168,519 |
| Purchase of shares | (148,594) | (139,359) | (148,705) |
| End of year | (526,644) | (548,084) | (592,128) |
| SERP - CLASS B COMMON STOCK | |||
| Beginning and end of year | (826,170) | (826,170) | (826,170) |
| Fiscal Years Ended | |||
|---|---|---|---|
| (dollars in thousands) | September 27, 2025 | September 28, 2024 | September 30, 2023 |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $235,028 | $208,786 | $175,156 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 94,013 | 85,878 | 77,763 |
| Amortization | 9,715 | 10,149 | 11,541 |
| Deferred income taxes | (6,545) | (29,651) | (34,997) |
| Equity-based compensation expense | 16,708 | 14,959 | 10,582 |
| Loss on sale of businesses | — | — | 900 |
| Asset impairment and inventory write-down | 13,848 | 29,176 | 18,973 |
| Gain on sale of buildings | — | (979) | (10,030) |
| Pension settlement | — | — | 12,542 |
| Other | 4,432 | 6,283 | 6,244 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | (87,070) | 35,962 | (69,275) |
| Unbilled receivables | (64,588) | (50,474) | (35,423) |
| Inventories | (51,772) | (131,330) | (127,442) |
| Accounts payable | 24,711 | 26,446 | 28,641 |
| Contract advances and progress billings | 81,597 | (41,717) | 39,448 |
| Accrued expenses | 3,743 | 7,900 | (3,185) |
| Accrued income taxes | (20,214) | 14,502 | 23,644 |
| Net pension and post retirement liabilities | 18,194 | 11,791 | 13,940 |
| Other assets and liabilities | 1,286 | 181 | 629 |
| Net cash provided (used) by operating activities | 273,086 | 197,862 | 139,651 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Acquisitions of businesses, net of cash acquired | (41,179) | (5,911) | — |
| Purchase of property, plant and equipment | (144,731) | (151,995) | (177,309) |
| Net proceeds from businesses sold | 13,487 | 1,627 | 1,892 |
| Net proceeds from buildings sold | — | 1,453 | 19,702 |
| Other investing transactions | (2,833) | (766) | (11,455) |
| Net cash provided (used) by investing activities | (175,256) | (155,592) | (167,170) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 1,229,500 | 1,038,500 | 1,044,101 |
| Payments on revolving lines of credit | (1,410,000) | (1,029,500) | (1,017,420) |
| Proceeds from long-term debt | 250,000 | — | — |
| Payments on long-term debt | — | — | (916) |
| Payments on finance lease obligations | (10,159) | (6,037) | (4,313) |
| Payment of dividends | (36,430) | (35,476) | (34,074) |
| Proceeds from sale of treasury stock | 19,568 | 15,685 | 19,785 |
| Purchase of outstanding shares for treasury | (142,707) | (36,738) | (29,306) |
| Proceeds from sale of stock held by SECT | 32,664 | 28,202 | 15,713 |
| Purchase of stock held by SECT | (28,985) | (22,837) | (14,251) |
| Other financing transactions | (1,742) | — | (2,027) |
| Net cash provided (used) by financing activities | (98,291) | (48,201) | (22,708) |
| Effect of exchange rate changes on cash | (1,863) | 1,324 | 2,043 |
| Increase (decrease) in cash, cash equivalents and restricted cash | (2,324) | (4,607) | (48,184) |
| Cash, cash equivalents and restricted cash at beginning of year(1) | 64,537 | 69,144 | 117,328 |
| Cash, cash equivalents and restricted cash at end of year (1) | $62,213 | $64,537 | $69,144 |
(1)Ending cash balance at September 28, 2024 and beginning cash at September 29, 2024, includes cash related to assets held for sale of $2,720.
| Consolidated Statements of Cash Flows, continued | |||
|---|---|---|---|
| Fiscal Years Ended | |||
| September 27, 2025 | September 28, 2024 | September 30, 2023 | |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Interest paid | $70,977 | $65,382 | $59,453 |
| Income taxes paid, net of refunds | 100,347 | 78,482 | 69,253 |
| Treasury shares issued as compensation | 6,289 | 5,323 | 4,174 |
| Treasury shares issued as consideration for acquisitions | 20,294 | — | — |
| Assets acquired through lease financing | 47,014 | 39,383 | 64,034 |
Notes to Consolidated Financial Statements(dollars in thousands, except per share data)
Note 1 -Summary of Significant Accounting Policies
Consolidation: The consolidated financial statements include the accounts of Moog Inc. and all of our U.S. and foreign subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Fiscal Year: Our fiscal year ends on the Saturday that is closest to September 30. The consolidated financial statements include 52 weeks for the years ended September 27, 2025, September 28, 2024 and September 30, 2023.
Operating Cycle: Consistent with industry practice, aerospace and defense related inventories, unbilled recoverable costs and profits on over-time contract receivables, customer advances, warranties and contract reserves include amounts relating to contracts having long production and procurement cycles, portions of which are not expected to be realized or settled within one year.
Foreign Currency Translation: Assets and liabilities of subsidiaries that prepare financial statements in currencies other than the U.S. dollar are translated using rates of exchange as of the balance sheet date and the statements of earnings are translated at the average rates of exchange for each reporting period.
Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates and assumptions.
Revenue Recognition: We recognize revenue from contracts with customers using an over-time, cost-to-cost method of accounting or at the point in time that control transfers to the customer. For additional discussion on revenue recognition, see Note 2 - Revenue from Contracts with Customers.
Cost of Sales: Includes costs of products and services sold, which include but are not limited to: purchased product, raw material, direct and engineering labor and related benefits, shipping and handling costs, depreciation and amortization, indirect costs and overhead charges.
Research and Development: Research and development costs are expensed as incurred and include salaries, benefits, consulting, material costs, depreciation and amortization.
Selling, General and Administrative Expenses: Selling, general and administrative expenses are expensed as incurred. Such expenses include, but are not limited to advertising, bid and proposal, consulting, depreciation, employee payroll and related benefits, legal and professional costs.
Government Assistance: We receive various types of government assistance, primary in the form of grants and refundable tax credits. We recognize government assistance when there is reasonable assurance that it will comply with the relevant conditions and the assistance will be received. Government assistance related to property, plant and equipment is recorded as a reduction to the carrying value of the related asset, which reduces depreciation expense over the expected useful life of the asset on a straight-line basis. See Note 4 – Receivables and Note 6 – Property, Plant and Equipment for additional disclosures related to government assistance.
Equity-Based Compensation: Our equity-based compensation plans allow for various types of equity-based incentive awards. The types and mix of these incentive awards are evaluated on an on-going basis and may vary based on our overall strategy regarding compensation. Equity-based compensation expense is based on awards that are ultimately expected to vest over the requisite service periods and are based on the fair value of the award measured on the grant date. Vesting requirements vary for directors, officers and key employees. In general, awards granted to officers and key employees principally vest over three years, in equal annual installments for time-based awards and inthree years cliff vest for performance-based awards. We have elected to account for forfeitures when the forfeiture of the underlying awards occur. Equity-based compensation expense is included in selling, general and administrative expenses.
Cash and Cash Equivalents: All highly liquid investments with an original maturity of three months or less are considered cash equivalents.
Restricted Cash: Restricted cash principally represents funds held to satisfy supplemental retirement obligations.
Allowance for Credit Losses: The allowance for credit losses is based on our assessment of the collectibility of customer accounts. The allowance is determined by considering factors such as historical experience, credit quality, age of the accounts receivable, current economic conditions and reasonable forecasted financial information that may affect a customer’s ability to pay.
Inventories: Inventories are stated at the lower of cost or net realizable value with cost determined primarily on the first-in, first-out (FIFO) method of valuation.
Property, Plant and Equipment: Property, plant and equipment are stated at cost. Plant and equipment are depreciated principally using the straight-line method over the estimated useful lives of the assets, generally ranging from 15 to 40 years for buildings and improvements,5 to 15 years for machinery and equipment and 3 to 10 years for computer equipment and software. Leasehold improvements are amortized on a straight-line basis over the term of the lease or the estimated useful life of the asset, whichever is shorter.
Capitalized Interest: The interest cost on certain long term capital projects is capitalized and included in the cost of the project. Capitalization begins with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. For the year ended September 27, 2025, we incurred total interest of $77,625 and capitalized $5,550, into property, plant and equipment. For the year ended September 28, 2024, we incurred total interest of $72,154 and capitalized $5,824 into property, plant and equipment. For the year ended September 30, 2023, we incurred total interest of $63,861 and capitalized $4,023 into property, plant and equipment.
Goodwill: We test goodwill for impairment at the reporting unit level on an annual basis or more frequently if an event occurs or circumstances change that indicate that the fair value of a reporting unit is likely to be below its carrying amount. We also test goodwill for impairment when there is a change in reporting units.
We may elect to perform a qualitative assessment that considers economic, industry and company-specific factors for all or selected reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we proceed to a quantitative test. We may also elect to perform a quantitative test instead of a qualitative assessment for any or all of our reporting units. We performed a qualitative test for all reporting units in 2025, 2024 and 2023.
Quantitative testing requires a comparison of the fair value of each reporting unit to its carrying value. We typically use the discounted cash flow method to estimate the fair value of our reporting units. The discounted cash flow method incorporates various assumptions, the most significant being projected revenue growth rates, operating margins and cash flows, the terminal growth rate and the weighted-average cost of capital. If the carrying value of the reporting unit exceeds its fair value, goodwill is considered impaired and any loss must be measured. To determine the amount of the impairment loss, the implied fair value of goodwill is determined by assigning a fair value to all of the reporting unit's assets and liabilities, including any unrecognized intangible assets, as if the reporting unit had been acquired in a business combination at fair value. If the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss would be recognized in an amount equal to that excess.
There wereno goodwill impairment charges recorded in 2025, 2024 or 2023.
Acquired Intangible Assets: Acquired identifiable intangible assets are recorded at fair value and are amortized over their estimated useful lives.
Impairment of Long-Lived Assets: Long-lived assets, including acquired identifiable intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of those assets may not be recoverable. We use undiscounted cash flows to determine whether impairment exists and measure any impairment loss using discounted cash flows.
In 2025, we recorded impairment charges on long-lived assets in our Industrial segment related to property and equipment that experienced a decline in value. These charges are included in asset impairment in the Consolidated Statements of Earnings.
In 2024, we initiated restructuring actions in conjunction with exiting a product line within our Military Aircraft segment and simplifying our business operations within our Industrial segment, both of which included the write off of intangible assets. We have recorded these charges based on the expected cash flows over the remaining life of the assets and are included in Restructuring in the Consolidated Statements of Earnings.
In 2023, we recorded an impairment charge on long-lived assets, as well as an inventory write-down in our Military Aircraft segment. These charges relate to equipment and inventory that experienced a decline in value due to the U.S. Air Force announcement to retire the KC-10 aerial refueling tanker and retirement of a trade name intangible. We also recorded impairment charges on receivables in our Space and Defense segment associated with an expected cancellation of a contract. In addition, we recorded impairment charges on long-lived assets, as well as an inventory write-down in our Industrial segment as we continue to review and simplify our business operations. These charges are included in asset impairment in the Consolidated Statements of Earnings.
See Note 4 - Receivables, Note 5 - Inventories, Note 6 - Property, Plant and Equipment, Note 7 - Leases and Note 8 - Goodwill and Intangible Assets for additional disclosures relating to impairment charges recorded.
Product Warranties: In the ordinary course of business, we warrant our products against defect in design, materials and workmanship typically over periods ranging from twelve tosixty months. We determine warranty reserves needed by product line based on historical experience and current facts and circumstances.
Financial Instruments: Our financial instruments consist primarily of cash and cash equivalents, restricted cash, receivables, notes payable, accounts payable, long-term debt, interest rate swaps and foreign currency contracts. The carrying values for our financial instruments approximate fair value with the exception at times of long-term debt. We do not hold or issue financial instruments for trading purposes.
We carry derivative instruments on the Consolidated Balance Sheets at fair value, determined by reference to quoted market prices. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, if so, the reason for holding it. Our use of derivative instruments is generally limited to cash flow hedges of certain interest rate risks and minimizing foreign currency exposure on foreign currency transactions, which are typically designated in hedging relationships, and intercompany balances, which are not designated as hedging instruments. Cash flows resulting from forward contracts are accounted for as hedges of identifiable transactions or events and classified in the same category as the cash flows from the items being hedged.
Employee Benefit Plans: The measurement date for plan assets and benefit obligations is the month end closest to our fiscal year end.
Recent Accounting Pronouncements:
Recent Accounting Pronouncements Adopted
| Standard | Description | Financial Statement Effect or Other Significant Matters |
|---|---|---|
| ASU no. 2023-07Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures | This standard requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources. The provisions of the standard are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendment requires retrospective application to all prior periods presented in the financial statements. | We adopted this standard using retrospective application to all prior periods presented. |
| Date adopted: Q4 2025 | ||
Recent Accounting Pronouncements Not Yet Adopted
| Standard | Description | Financial Statement Effect or Other Significant Matters |
|---|---|---|
| ASU no. 2023-09Income Taxes (Topic 740): Improvements to Income Tax Disclosures | This standard expands annual income tax disclosures to require specific categories in the rate reconciliation table to be disclosed using both percentages and reporting currency amounts and requires additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires disclosure of income taxes paid by jurisdiction. The provisions of the standard are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application is permitted. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. |
| Planned date of adoption: FY 2026 | ||
| ASU no. 2024-03Income Statement -Reporting Comprehensive Income-Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses | This standard requires disclosure of specified information about certain cost and expenses at each interim and annual reporting period. This includes disclosure of the amounts of purchases of inventory, employee compensation, depreciation and intangible asset for each relevant expense caption on the income statement, as well as the total amount of selling expenses. Additionally, the amendments require disclosing a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The provisions of the standard are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to all prior periods presented in the financial statements. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. |
| Planned date of adoption: FY 2028 | ||
We consider the applicability and impact of all Accounting Standard Updates ("ASU"). ASUs not listed above were assessed and determined to be either not applicable, or had or are expected to have an immaterial impact on our financial statements and related disclosures.
Revision of Previously Issued Consolidated Financial Statements: During the preparation of our consolidated financial statements for the year ended September 27, 2025, management identified misstatements in previously issued consolidated financial statements and interim consolidated condensed financial statements, impacting prior periods.
The principal misstatement related to the accounting for distinct long-term aftermarket service contracts with customers in the Commercial Aircraft segment. Specifically, there were inaccurate inputs used in the total costs at completion estimate within the over-time revenue recognition calculation for these contracts that accumulated over several years. Additionally, other unrelated misstatements, including an adjustment for the understatement of certain warranty costs, were also identified.
We evaluated the nature and magnitude of all identified misstatements to assess the materiality, including quantitative and qualitative considerations and determined that the misstatements were not material, individually or in aggregate, to any previously issued quarterly or annual consolidated financial statements. However, correcting these misstatements entirely in the current period would have been material to our 2025 financial statements. As a result, within this annual report, we have revised our prior period annual consolidated financial statements for 2023 and 2024 and our quarterly consolidated condensed financial statements for 2024 and 2025 to reflect the corrections in the periods in which the misstatements originated.
Correcting the misstatement related to long-term aftermarket service contracts, which originated prior to 2023, had a cumulative impact that decreased opening Retained earnings as of October 2, 2022 by $30,920. The correction of this misstatement also increased Net sales and decreased Cost of sales for the year ended 2023 by $436 and $2,024, respectively and decreased Net sales and Cost of sales for the year ended 2024 by $200 and $8,092, respectively.
Correcting the misstatement related to warranty costs, which originated prior to 2023, had a cumulative impact that decreased opening Retained earnings as of October 2, 2022 by $8,400. The correction of this misstatement also increased Cost of sales for the year ended 2023 by $300 and decreased Cost of sales for the year ended 2024 by $1,200.
A summary of the corrections and their related impacts on each financial statement line items from our previously issued consolidated financial statements are presented in Note 25 – Revision of Previously Issued Consolidated Financial Statements.
Note 2 -Revenue from Contracts with Customers
We recognize revenue from contracts with customers using the five-step model prescribed in ASC 606. The first step is identifying the contract. The identification of a contract with a customer requires an assessment of each party’s rights and obligations regarding the products or services to be transferred, including an evaluation of termination clauses and presently enforceable rights and obligations. Each party’s rights and obligations and the associated terms and conditions are typically determined in purchase orders. For sales that are governed by master supply agreements under which provisions define specific program requirements, purchase orders are issued under these agreements to reflect presently enforceable rights and obligations for the units of products and services being purchased.
Contracts are sometimes modified to account for changes in contract specifications and requirements. When this occurs, we assess the modification as prescribed in ASC 606 and determine whether the existing contract needs to be modified (and revenue cumulatively caught up), whether the existing contract needs to be terminated and a new contract needs to be created, or whether the existing contract remains and a new contract needs to be created. This is determined based on the rights and obligations within the modification as well as the associated transaction price.
The next step is identifying the performance obligations. A performance obligation is a promise to transfer goods or services to a customer that is distinct in the context of the contract, as defined by ASC 606. We identify a performance obligation for each promise in a contract to transfer a distinct good or service to the customer. As part of our assessment, we consider all goods and/or services promised in the contract, regardless of whether they are explicitly stated or implied by customary business practices. The products and services in our contracts are typically not distinct from one another due to their complexity and reliance on each other or, in many cases, we provide a significant integration service. Accordingly, many of our contracts are accounted for as one performance obligation. In limited cases, our contracts have more than one distinct performance obligation, which occurs when we perform activities that are not highly complex or interrelated or involve different product life cycles. Warranties are provided on certain contracts, but do not typically provide for services beyond standard assurances and are therefore not distinct performance obligations under ASC 606.
The third step is determining the transaction price, which represents the amount of consideration we expect to be entitled to receive from a customer in exchange for providing the goods or services. There are times when this consideration is variable, for example a volume discount, and must be estimated. Sales, use, value-added, and excise taxes are excluded from the transaction price, where applicable.
The fourth step is allocating the transaction price. The transaction price must be allocated to the performance obligations identified in the contract based on relative stand-alone selling prices when available, or an estimate for each distinct good or service in the contract when standalone prices are not available. Our contracts with customers generally require payment under normal commercial terms after delivery. Payment terms are typically within 30 to 60 days of delivery. The timing of satisfaction of our performance obligations does not significantly vary from the typical timing of payment.
The final step is the recognition of revenue. We recognize revenue as the performance obligations are satisfied. ASC 606 provides guidance to help determine if we are satisfying the performance obligation at a point in time or over time. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative use of the product or service. In essence, we recognize revenue when, or as control of, the promised goods or services transfer to the customer.
Revenue is recognized using either the over time or point in time method. The over-time method of revenue recognition is predominantly used in Space and Defense, Military Aircraft and Commercial Aircraft. We use this method for U.S. Government contracts and repair and overhaul arrangements as we are creating or enhancing assets that the customer controls as the assets are being created or enhanced. In addition, many of our large commercial contracts qualify for over-time accounting as our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed to date. Our over-time contracts are primarily firm fixed price.
Revenue recognized at the point in time control is transferred to the customer is used most frequently in Industrial. We use this method for commercial contracts in which the asset being created has an alternative use. We determine the point in time control transfers to the customer by weighing the five indicators provided by ASC 606 - the entity has a present right to payment; the customer has legal title; the customer has physical possession; the customer has significant risks and rewards of ownership; and the customer has accepted the asset. When control has transferred to the customer, profit is generated as cost of sales is recorded and as revenue is recognized. Inventory costs include all product manufacturing costs such as direct material, direct labor, other direct costs and indirect overhead cost allocations. Shipping and handling costs are considered costs to fulfill a contract and not considered performance obligations. They are included in cost of sales as incurred.
Revenue is recognized over time on contracts using the cost-to-cost method of accounting as work progresses toward completion as determined by the ratio of cumulative costs incurred to date to estimated total contract costs at completion, multiplied by the total estimated contract revenue, less cumulative revenue recognized in prior periods. We believe that cumulative costs incurred to date as a percentage of estimated total contract costs at completion is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of our work and transfer of control to our customers. Changes in estimates affecting sales, costs and profits are recognized in the period in which the change becomes known using the cumulative catch-up method of accounting, resulting in the cumulative effect of changes reflected in the period. Estimates are reviewed and updated quarterly for substantially all contracts. In 2025, we recognized higher revenues of $11,640 for adjustments made to performance obligations satisfied (or partially satisfied) in previous periods. In 2024, we recognized lower revenues of $9,409 for adjustments made to performance obligations satisfied (or partially satisfied) in previous periods. In 2023, we recognized lower revenues of $3,095 for adjustments made to performance obligations satisfied (or partially satisfied) in previous periods.
Contract costs include only allocable, allowable and reasonable costs which are included in cost of sales when incurred. For applicable U.S. Government contracts, contract costs are determined in accordance with the Federal Acquisition Regulations and the related Cost Accounting Standards. The nature of these costs includes development engineering costs and product manufacturing costs such as direct material, direct labor, other direct costs and indirect overhead costs. Contract profit is recorded as a result of the revenue recognized less costs incurred in any reporting period. Variable consideration and contract modifications, such as performance incentives, penalties, contract claims or change orders are considered in estimating revenues, costs and profits when they can be reliably estimated and realization is considered probable. As of September 27, 2025, revenue recognized on contracts for unresolved claims or unapproved contract change orders was not material.
As of September 27, 2025, we had contract reserves of $84,360. For contracts with anticipated losses at completion, a provision for the entire amount of the estimated remaining loss is charged against income in the period in which the loss becomes known. Contract losses are determined considering all direct and indirect contract costs, exclusive of any selling, general or administrative cost allocations that are treated as period expenses. Loss reserves are more common on firm fixed-price contracts that involve, to varying degrees, the design and development of new and unique controls or control systems to meet the customers’ specifications. We calculate contract losses at the contract level, versus the performance obligation level. Recall reserves are recorded when additional work is needed on completed products for them to meet contract specifications. Contract-related loss reserves are recorded for the additional work needed on completed and delivered products in order for them to meet contract specifications.
Contract Assets and Liabilities
Unbilled receivables (contract assets) primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. Unbilled receivables are classified as current assets and in accordance with industry practice, include amounts that may be billed and collected beyond one year due to the long term nature of our contracts.
Contract advances and progress billings (contract liabilities) relate to payments received from customers in advance of the satisfaction of performance obligations for a contract (contract advances) and when billings are in excess of revenue recognized (progress billings). These amounts are recorded as contract liabilities until such obligations are satisfied, either over-time as costs are incurred or at a point when deliveries are made. We do not consider contract advances and progress billings to be significant financing components as the intent of these payments in advance are for reasons other than providing a significant financing benefit and are customary in our industry.
For contracts recognized using the cost-to-cost method, the amount of unbilled receivables or contract advances and progress billings is determined for each contract to determine the contract asset or contract liability position at the end of each reporting period.
Unbilled recoverable costs and accrued profits for over-time contracts to be billed to the U.S. Government were $12,111 at September 27, 2025 and $20,394 at September 28, 2024. Unbilled recoverable costs and accrued profits principally represent revenues recognized on contracts that were not billable on the balance sheet date. These amounts will be billed in accordance with contract terms, generally as certain milestones are reached or upon shipment. Unbilled amounts expected to be collected beyond one year are not material.
Total contract assets and contract liabilities are as follows:
| September 27,2025 | September 28,2024 | |
|---|---|---|
| Unbilled receivables | $744,352 | $690,572 |
| Contract advances and progress billings | 372,988 | 302,126 |
| Net contract assets | $371,364 | $388,446 |
The decrease in net contract assets primarily reflects the impact of additional unbilled revenues and an increase in contract advances and progress billings during the period. As of September 27, 2025, we recognized $235,130 of revenue, that was included in the contract liability balance at the beginning of the year.
Remaining Performance Obligations
As of September 27, 2025, the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) was $6,010,000. We expect to recognize approximately 50% of that amount as sales over the next twelve months and the balance thereafter.
Disaggregation of Revenue
See Note 22 - Segments, for disclosures related to disaggregation of revenue.
Note 3 -Acquisitions, Divestitures and Assets Held for Sale
Acquisitions
On July 1, 2025, we acquired COTSWORKS, Inc. ("COTSWORKS"), based in Ohio for a purchase price, net of cash acquired, of $61,473, which was paid in cash and the issuance of Moog Class A shares valued at $20,294. At September 27, 2025, we have ascribed $12,000 of the purchase price to intangible assets. COTSWORKS designs and manufactures rugged optical components and subsystems for harsh environment applications, primarily serving the commercial, military, aerospace and industrial markets. The purchase price allocation is substantially complete, with the exception of income tax assets and liabilities. This operation is included in our Space and Defense segment. The sales and results of COTSWORKS are immaterial in 2025.
On October 20, 2023, we acquired Data Collection Limited ("DCL") based in Auckland, New Zealand for a purchase price, net of acquired cash, of $5,911. DCL specializes in manufacturing and operating pavement surveying equipment and providing innovative solutions for measuring and managing pavements. This operation is included in our Military Aircraft segment. The sales and results of operations of DCL are immaterial in 2025 and 2024.
Divestitures
In the fourth quarter of 2024, we recorded losses in Asset impairment and fair value adjustment of $14,897, related to selling a motors business in the Czech Republic and a hydraulic systems business in Luxembourg that were included in our Industrial segment. As a result, we have classified $9,360 in prepaid expenses and other current assets and $5,153 in accrued liabilities and other as held for sale at September 28, 2024. We completed the sale of these businesses on September 30, 2024, which required the release of the associated cumulative translation adjustment. There has been no significant change to the losses recognized as a result of completing the transactions.
Assets Held for Sale
As of the third quarter of 2025, we have classified a non-core business within our Space and Defense segment as held for sale. We have classified $61,067 in prepaid expenses and other current assets and $15,524 in accrued liabilities and other as held for sale. See Note 8 - Goodwill and Intangible Assets for additional details.
Note 4 - Receivables
Receivables consist of:
| September 27,2025 | September 28,2024 | |
|---|---|---|
| Accounts receivable | $483,872 | $388,841 |
| Government assistance receivables | 5,643 | 16,673 |
| Other | 19,856 | 17,530 |
| Less allowance for credit losses | (2,603) | (3,073) |
| Receivables, net | $506,768 | $419,971 |
Moog Receivables LLC (the "Receivables Subsidiary"), a wholly owned bankruptcy remote special purpose subsidiary of Moog Inc. (the "Company"), as seller, the Company, as master servicer, Wells Fargo Bank, N.A., as administrative agent (the "Agent") and certain purchasers (collectively, the "Purchasers") entered into the Third Amendment to the Amended and Restated Receivables Purchase Agreement (the "RPA"). The RPA matures on December 11, 2026 and is subject to customary termination events related to transactions of this type.
Under the RPA, the Receivables Subsidiary may sell receivables to the Purchasers in amounts up to a $125,000 limit. The receivables will be sold to the Purchasers in consideration for the Purchasers making payments of cash, which is referred to as "capital" for purposes of the RPA, to the Receivables Subsidiary in accordance with the terms of the RPA. The Receivables Subsidiary may sell receivables to the Purchasers so long as certain conditions are satisfied, including that, at any date of determination, the aggregate capital paid to the Receivables Subsidiary does not exceed a "capital coverage amount," equal to an adjusted net receivables pool balance minus a required reserve. Each Purchaser's share of capital accrues yield at a variable rate plus an applicable margin.
The parties intend that the conveyance of receivables to the Agent, for the ratable benefit of the Purchasers will constitute a purchase and sale of receivables and not a pledge for security. The Receivables Subsidiary has guaranteed to each Purchaser and Agent the prompt payment of sold receivables, and to secure the prompt payment and performance of such guaranteed obligations, the Receivables Subsidiary has granted a security interest to the Agent, for the benefit of the Purchasers, in all assets of the Receivables Subsidiary. The assets of the Receivables Subsidiary are not available to pay our creditors or any affiliate thereof. In our capacity as master servicer under the RPA, we are responsible for administering and collecting receivables and have made customary representations, warranties, covenants and indemnities.
The proceeds of the RPA are classified as operating activities in our Consolidated Statements of Cash Flows. Cash received from collections of sold receivables is used by the Receivables Subsidiary to fund additional purchases of receivables on a revolving basis or to return all or any portion of outstanding capital of the Purchaser. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows at the time of collection. Total receivables sold and cash collections under the RPA were $680,709 for the year ended September 27, 2025. The fair value of the sold receivables approximated book value due to their credit quality and short-term nature, and as a result, no gain or loss on sale of receivables was recorded.
The amount sold to the Purchasers was $125,000 at September 27, 2025, which was derecognized from the Consolidated Balance Sheets. As collateral against sold receivables, the Receivables Subsidiary maintains a certain level of unsold receivables, which was $668,021 at September 27, 2025.
Over-time contract receivables are primarily associated with prime contractors and subcontractors in connection with U.S. Government contracts, as well as commercial aircraft and satellite manufacturers. Amounts billed for over-time contracts to the U.S. Government were $1,668 at September 27, 2025 and $3,952 at September 28, 2024.
There are no material amounts of claims or unapproved change orders included in the Consolidated Balance Sheets. There are no material balances billed but not paid by customers under retainage provisions.
Concentrations of credit risk on receivables are limited to those from significant customers who are believed to be financially sound. Receivables, both billed and unbilled from Boeing were $263,140 at September 27, 2025 and $242,096 at September 28, 2024 and receivables, both billed and unbilled from Lockheed Martin were $138,246 at September 27, 2025 and $122,816 at September 28, 2024. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral.
In 2020 the U.S. government enacted the Coronavirus Aid, Relief and Economics Security Act (the "CARES Act") to provide relief as a result of the COVID-19 pandemic. The CARES Act provides tax relief, along with other stimulus measures, including a provision for an Employee Retention Credit ("ERC"), which allows employers to claim a refundable tax credit against the employer share of Social Security tax equal to 70% of the qualified wages paid to employees.
In 2025, an additional $3,320 was received for ERC under the CARES Act and was recorded as contra expense to personnel related costs of $3,084 to Costs of sales and $236 to Selling, general and administrative costs in our Consolidated Statement of Earnings.
In 2024, we applied for the ERC under the CARES Act and recorded contra expense to personnel related costs of $13,247 to Costs of sales and $1,012 to Selling, general and administrative costs in our Consolidated Statement of Earnings in 2024 and is included in Receivables on our Consolidated Balance Sheets at September 28, 2024.
We qualify for New York State ("NYS") Excelsior Jobs Program tax credits, which relate to increasing and maintaining employee headcount, amounts of capital investments and research and development spending in NYS. The initial program allows us to receive up to $8,500 of refundable tax credits in cash over a nine year period. A second program allows us to receive up to $16,400 of refundable tax credits in cash over a ten year period. As long as the annual requirements are met and maintained, we will receive the credits without any clawback provisions. We have recorded the tax credits for the initial program as a contra expense topersonnel related costs and research and development in our Consolidated Statement of Earnings for $1,956, $1,118 and $1,118 in 2025, 2024 and 2023, respectively. We have recorded the tax credits for the second program as a contra expense to personnel related costs in our Consolidated Statement of Earnings for $2,509 in 2025. We have $3,074 and $2,236, recorded as Receivables for the initial program credits on our Consolidated Balance Sheets at September 27, 2025 and September 28, 2024, respectively. We have $2,509, recorded as Receivables for the second program on our Consolidated Balance Sheets at September 27, 2025. As of September 27, 2025 we have future tax credits of $15,289 that we can receive through 2033, if we maintain the annual requirements.
The allowance for credit losses is based on our assessment of the collectability of customer accounts. The allowance is determined by considering factors such as historical experience, credit quality, age of the accounts receivable, current economic conditions and reasonable forecasted financial information that may affect a customer’s ability to pay.
Note 5 -Inventories
Inventories, net of reserves, consist of:
| September 27,2025 | September 28,2024 | |
|---|---|---|
| Raw materials and purchased parts | $301,679 | $291,969 |
| Work in progress | 520,315 | 488,342 |
| Finished goods | 92,308 | 82,230 |
| Inventories, net | $914,302 | $862,541 |
There are no material inventoried costs relating to over-time contracts where revenue is accounted for using the cost-to-cost method of accounting as of September 27, 2025 and September 28, 2024.
We have recorded inventory write-downs, primarily as a result of excess and obsolete inventories related to restructuring actions taken to close facilities and transfer remaining production and for the retirement or exiting the business of specific programs. See Note 14 - Restructuring and Note 22 - Segments, for additional disclosures relating to inventory write-downs.
Note 6 -Property, Plant and Equipment
Property, plant and equipment consists of:
| September 27,2025 | September 28,2024 | |
|---|---|---|
| Land | $33,872 | $32,270 |
| Buildings and improvements | 737,053 | 698,333 |
| Machinery and equipment | 981,157 | 901,643 |
| Computer equipment and software | 253,924 | 237,604 |
| Property, plant and equipment, at cost | 2,006,006 | 1,869,850 |
| Less accumulated depreciation and amortization | (986,100) | (941,262) |
| Property, plant and equipment, net | $1,019,906 | $928,588 |
In 2025, we recorded $2,374 of impairment charges on property and equipment on owned assets that experienced a decline in value, based on expected cash flows over the remaining life of the assets in relation to a decline in the related business in our Industrial segment. In 2024, we recorded $806 of impairment charges on equipment no longer in use. In 2023, we recorded $5,301 of impairment charges on property and equipment on owned assets that experienced a decline in value, based on expected cash flows over the remaining life of the assets in relation to a decline in the related business in our Industrial segment and from the retirement of a program in our Military Aircraft segment.
In 2025, we received $2,222 in cash from the US Department of Defense for production equipment to be used on existing contracts and for the construction of a training facility. A total of $1,105 has been recorded as a reduction of property, plant and equipment in 2025 when the expenditures took place and the remaining $1,117 is recorded as an accrued liability on the Consolidated Balance Sheets and will be offset against the capital expenditures when they are incurred.
In 2024, we received $6,243 in cash from NYS for capital expenditures in relation to the remediation of a brownfield at our East Aurora facilities. The credit was recorded as a reduction of property, plant and equipment in 2020 when the expenditures were made and the requirements of the tax credit were fulfilled.
Note 7 -Leases
We lease certain manufacturing facilities, office space and machinery and equipment globally. At inception we evaluate whether a contractual arrangement contains a lease. Specifically, we consider whether we control the underlying asset and have the right to obtain substantially all the economic benefits or outputs from the asset. If the contractual arrangement contains a lease, we then determine the classification of the lease, operating or finance, using the classification criteria described in ASC 842. We then determine the term of the lease based on terms and conditions of the contractual arrangement, including whether the options to extend or terminate the lease are reasonably certain to be exercised. We have elected to not separate lease components from non-lease components, such as common area maintenance charges and instead, account for the lease and non-lease components as a single component.
Our lease right-of-use ("ROU") assets represent our right to use an underlying asset for the lease term and our lease liabilities represent our obligation to make lease payments. The ROU assets and lease liabilities for both operating and finance leases are recognized as of the commencement date at the net present value of the fixed minimum lease payments over the term of the lease including expected buyouts, using the discount rate described below. Variable lease payments are recorded in the period in which the obligation for the payment is incurred. Variable lease payments based on an index or rate are initially measured using the index or rate as of the commencement date of the lease and included in the fixed minimum lease payments. For short-term leases that have a term of 12 months or less as of the commencement date, we do not recognize a ROU asset or lease liability on our balance sheet; we recognize expense as the lease payments are made over the lease term.
Operating lease cost is included in Cost of sales and Selling, general and administrative on the Consolidated Statements of Earnings. Finance lease cost is included in Cost of sales, Selling, general and administrative and Interest on the Consolidated Statements of Earnings.
The discount rate used to calculate the present value of our leases is the rate implicit in the lease. If the information necessary to determine the rate implicit in the lease is not available, we use our incremental borrowing rate for collateralized debt, which is determined using our credit rating and other information available as of the lease commencement date.
The components of lease expense were as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating lease cost | $32,428 | $31,065 | $29,982 |
| Finance lease cost: | |||
| Amortization of right-of-use assets | $10,909 | $7,443 | $4,380 |
| Interest on lease liabilities | 7,623 | 5,963 | 3,247 |
| Total finance lease cost | $18,532 | $13,406 | $7,627 |
Supplemental cash flow information related to leases was as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Operating cash flow for operating leases | $33,495 | $31,346 | $30,281 |
| Operating cash flow for finance leases | 7,623 | 5,963 | 3,247 |
| Financing cash flow for finance leases | 10,159 | 6,037 | 4,313 |
| Assets obtained in exchange for lease obligations: | |||
| Operating leases | 13,462 | 10,162 | 6,014 |
| Finance leases | 33,552 | 29,221 | 58,020 |
Supplemental balance sheet information related to leases was as follows:
| September 27, 2025 | September 28, 2024 | |
|---|---|---|
| Operating Leases: | ||
| Operating lease right-of-use assets | $52,799 | $52,591 |
| Accrued liabilities and other | $11,697 | $11,124 |
| Other long-term liabilities | 52,549 | 53,228 |
| Total operating lease liabilities | $64,246 | $64,352 |
| Finance Leases: | ||
| Property, plant, and equipment, at cost | $157,533 | $124,770 |
| Accumulated depreciation | (27,186) | (17,101) |
| Property, plant, and equipment, net | $130,347 | $107,669 |
| Accrued liabilities and other | $14,920 | $8,713 |
| Other long-term liabilities | 119,155 | 101,683 |
| Total finance lease liabilities | $134,075 | $110,396 |
| Weighted average remaining lease term in years: | ||
| Operating leases | 6.2 | 6.2 |
| Finance leases | 17.6 | 20.1 |
| Weighted average discount rates: | ||
| Operating leases | 5.3% | 5.2% |
| Finance leases | 6.4% | 6.4% |
Maturities of lease liabilities were as follows:
| Operating Leases · Finance Leases | ||
|---|---|---|
| 2026 | $14,566 | $22,296 |
| 2027 | 13,698 | 19,885 |
| 2028 | 11,571 | 20,801 |
| 2029 | 10,098 | 21,824 |
| 2030 | 7,467 | 18,678 |
| Thereafter | 18,132 | 143,900 |
| Total lease payments | 75,532 | 247,384 |
| Less: imputed interest | (11,286) | (113,309) |
| Total | $64,246 | $134,075 |
The operating lease ROU and finance lease disclosures above reflect a write down of $2,849 in 2024, as a result of restructuring actions taken to simplify our business operations through facility closures.
Note 8 -Goodwill and Intangible Assets
The changes in the carrying amount of goodwill are as follows:
| Space andDefense | Military Aircraft | Commercial Aircraft | Industrial | Total | |
|---|---|---|---|---|---|
| Balance at October 1, 2022 | $259,407 | $106,907 | $92,612 | $346,394 | $805,320 |
| Adjustments to prior year acquisitions | — | 122 | — | — | 122 |
| Foreign currency translation | 68 | 4,247 | — | 11,544 | 15,859 |
| Balance at September 30, 2023 | 259,475 | 111,276 | 92,612 | 357,938 | 821,301 |
| Acquisition | — | 2,760 | — | — | 2,760 |
| Held for sale | — | — | — | (3,719) | (3,719) |
| Foreign currency translation | 76 | 4,906 | — | 8,440 | 13,422 |
| Balance at September 28, 2024 | 259,551 | 118,942 | 92,612 | 362,659 | 833,764 |
| Acquisition | 36,191 | — | — | — | 36,191 |
| Held for sale | (33,000) | — | — | — | (33,000) |
| Foreign currency translation | (2) | (397) | — | 5,757 | 5,358 |
| Balance at September 27, 2025 | $262,740 | $118,545 | $92,612 | $368,416 | $842,313 |
Goodwill in our Space and Defense segment is net of a $4,800 accumulated impairment loss at September 27, 2025 and September 28, 2024. Goodwill in our Medical Devices reporting unit, included in our Industrial segment, is net of a $38,200 accumulated impairment loss at September 27, 2025 and September 28, 2024.
The components of intangible assets are as follows:
| September 27, 2025 · September 28, 2024 | |||||
|---|---|---|---|---|---|
| Weighted-AverageLife (years) | Gross CarryingAmount | AccumulatedAmortization | Gross CarryingAmount | AccumulatedAmortization | |
| Customer-related | 11 | $131,967 | $(100,655) | $130,092 | $(96,307) |
| Technology-related | 9 | 77,172 | (57,817) | 68,275 | (56,236) |
| Program-related | 23 | 39,799 | (26,476) | 39,865 | (24,887) |
| Marketing-related | 8 | 21,387 | (19,320) | 22,141 | (19,486) |
| Other | 3 | 1,376 | (1,332) | 1,407 | (1,385) |
| Intangible assets | 12 | $271,701 | $(205,600) | $261,780 | $(198,301) |
All acquired intangible assets other than goodwill are being amortized. Customer-related intangible assets primarily consist of customer relationships. Technology-related intangible assets primarily consist of technology, patents and intellectual property. Program-related intangible assets consist of long-term programs represented by current contracts and probable follow on work. Marketing-related intangible assets primarily consist of trademarks and trade names.
In 2024, we recorded charges of $2,345 related to restructuring actions in conjunction with exiting product lines within our Industrial and Military Aircraft segments, respectively, both of which included the write off of intangible assets. We have recorded these charges based on the expected cash flows over the remaining life of the assets and are included in Restructuring in the Consolidated Statements of Earnings. In 2023, we recorded $4,409 in impairment charges on long-lived assets in our Industrial and Commercial Aircraft segments. These charges relate to a decline in value with the associated business and the retirement of a trade name intangible and are included asasset impairment in the Consolidated Statements of Earnings.
Amortization of acquired intangible assets is as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Acquired intangible asset amortization | $9,702 | $10,131 | $11,514 |
Based on acquired intangible assets recorded at September 27, 2025, amortization is estimated to be approximately:
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Estimated future amortization of acquired intangible assets | $10,900 | $9,900 | $9,000 | $7,400 | $5,300 |
Note 9 -Equity Method and Other Investments
Investments and operating results in which we do not have a controlling interest, however we do have the ability to exercise significant influence over operations are accounted for using the equity method of accounting. Net investment balances for equity method investments and joint ventures are included as Other assets in the Consolidated Balance Sheets and consist of:
| September 27, 2025 | September 28, 2024 | |
|---|---|---|
| Moog Aircraft Service Asia | $2,165 | $1,742 |
| Suffolk Technologies Fund 1, L.P. | 3,113 | 1,659 |
| Net investment balance | $5,278 | $3,401 |
Income and losses from equity method investments and joint ventures are included in Other in the Consolidated Statement of Earnings. In 2025, we recognized income of $409. In 2024 and 2023, we recognized losses of $226 and $62, respectively.
Moog Aircraft Services Asia ("MASA") is a joint venture included in our Commercial Aircraft segment in which we currently hold a 51% ownership share. MASA is intended to provide maintenance, repair and overhaul services for our manufactured flight control systems.
Suffolk Technologies Fund 1, L.P., is a limited partnership included in our Industrial segment that invests in startups to transform the construction, real estate and property maintenance industries in the U.S. We have a remaining on-call capital commitment of up to $4,774.
Hybrid Motion Solutions (“HMS”) is a joint venture in our Industrial segment in which we hold a 50% ownership interest. HMS specializes in hydrostatic servo drives and leverages synergies to enter new markets. The joint venture focuses on research and development, design and assembly as well as service. Our share of cumulative losses to date has exceeded our initial investment, and as such, we hadno net investment balance recorded as of September 27, 2025. In addition to the investment, we had a loan to HMS for $2,613, which we wrote off during 2023 and is included in Asset Impairment in the Consolidated Statements of Earnings.
Investments in, and the operating results of, entities in which we do not have a controlling financial interest or the ability to exercise significant influence over the operations are accounted for at historical cost or fair value using readily determinable financial information. In 2025, we recorded a $3,000 impairment for the devaluation of an investment, which is included in Asset impairment in the Consolidated Statements of Earnings. In 2024, we recorded an impairment for the devaluation of an investment of $5,294, which is included as asset impairment in the Consolidated Statements of Earnings. We had investments of $1,580 and $4,580 as of September 27, 2025 and September 28, 2024, respectively, which are included as Other assets in the Consolidated Balance Sheets.
Note 10 -Indebtedness
We maintain short-term line of credit facilities with banks throughout the world that are principally demand lines subject to revision by the banks.
Long-term debt consists of:
| September 27,2025 | September 28,2024 | |
|---|---|---|
| U.S. revolving credit facility | $195,000 | $375,500 |
| Term loan | 250,000 | — |
| SECT revolving credit facility | 1,000 | 1,000 |
| Senior notes 4.25% | 500,000 | 500,000 |
| Senior debt | 946,000 | 876,500 |
| Less deferred debt issuance cost | (314) | (2,361) |
| Less current installments | (1,563) | — |
| Long-term debt | $944,123 | $874,139 |
Our U.S. revolving credit facility, which matures on October 27, 2027, has a capacity of $1,100,000 and provides an expansion option, which permits us to request an increase of up to $400,000 to the credit facility upon satisfaction of certain conditions. The weighted-average interest rate on the outstanding U.S revolving credit facility borrowings is 5.80% and is based on SOFR plus the applicable margin, which was 1.60% at September 27, 2025. On May 30, 2025, we amended and restated our loan agreement to include a $250,000 term loan, with installment payments of $3,125 in 2026, $9,375 in 2027 and the remaining balance on the maturity date of October 27, 2027. Additional principal payments may be required under certain conditions. The proceeds of the term loan were used to pay down outstanding revolver borrowings of the U.S. revolving credit facility. The interest rate on the term loan borrowings was 5.90% and is based on SOFR plus the applicable margin, which was 1.60% at September 27, 2025. The U.S. revolving credit facility and term loan are secured by substantially all of our U.S. assets and contain various covenants which, among others, specify interest coverage and maximum leverage. We are in compliance with all covenants.
On November 6, 2024, the SECT amended the revolving credit facility, which reduced the borrowing capacity from $35,000 to $25,000 and extended the maturity date from October 26, 2025 to October 26, 2026. Interest is based on SOFR plus an applicable margin of 2.23%. A commitment fee is also charged based on a percentage of the unused amounts available and is not material.
We have $500,000 aggregate principal amount of 4.25% senior notes due December 15, 2027 with interest paid semiannually on June 15 and December 15 of each year. The senior notes are unsecured obligations, guaranteed on a senior unsecured basis by certain subsidiaries and contain normal incurrence-based covenants and limitations such as the ability to incur additional indebtedness, pay dividends, make other restricted payments and investments, create liens and certain corporate acts such as mergers and consolidations. We are in compliance with all covenants. The effective interest rate for these notes after considering the amortization of deferred debt issuance costs is 4.60%.
Maturities of long-term debt are:
| 2026 | 2027 | 2028 | 2029 | 2030 | Thereafter | |
|---|---|---|---|---|---|---|
| Long-term debt maturities | $3,125 | $10,375 | $932,500 | $— | $— | $— |
At September 27, 2025, we had pledged assets with a net book value of $2,163,282 as security for long-term debt.
At September 27, 2025, we had $925,388 of unused short and long-term borrowing capacity, including $900,721 from the U.S. revolving credit facility.
Commitment fees are charged on some of these arrangements and on the U.S. revolving credit facility based on a percentage of the unused amounts available and are not material.
Note 11 -Other Accrued Liabilities
Other accrued liabilities consists of:
| September 27, 2025 | September 28, 2024 | |
|---|---|---|
| Employee benefits | $57,019 | $55,032 |
| Contract reserves | 84,360 | 81,180 |
| Warranty accrual | 23,892 | 23,548 |
| Accrued income taxes | 30,392 | 51,058 |
| Other | 124,412 | 102,555 |
| Other accrued liabilities | $320,075 | $313,373 |
Activity in the warranty accrual is summarized as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Warranty accrual at beginning of period | $23,548 | $22,939 | $23,072 |
| Warranties issued during current period | 8,060 | 9,953 | 11,227 |
| Adjustments to pre-existing warranties | (2,824) | (1,830) | (350) |
| Reductions for settling warranties | (4,997) | (7,817) | (11,264) |
| Divestiture and held for sale adjustment | — | (33) | — |
| Foreign currency translation | 105 | 336 | 254 |
| Warranty accrual at end of period | $23,892 | $23,548 | $22,939 |
Note 12 -Derivative Financial Instruments
We principally use derivative financial instruments to manage foreign exchange risk related to foreign operations and foreign currency transactions. We enter into derivative financial instruments with a number of major financial institutions to minimize counterparty credit risk.
Derivatives designated as hedging instruments
We use foreign currency contracts as cash flow hedges to effectively fix the exchange rates on future payments and revenue. To mitigate exposure in movements between various currencies, including the Philippine peso, we had outstanding foreign currency contracts with notional amounts of $35,620 at September 27, 2025. These contracts mature at various times through December 23, 2026.
Foreign currency contracts are recorded in the Consolidated Balance Sheets at fair value and the related gains or losses are deferred in Shareholders’ Equity as a component of Accumulated Other Comprehensive Income (Loss) ("AOCIL"). These deferred gains and losses are reclassified into the Consolidated Statements of Earnings, as necessary, during the periods in which the related payments or receipts affect earnings. However, to the extent the foreign currency contracts are not perfectly effective in offsetting the change in the value of the payments and revenue being hedged, the ineffective portion of these contracts is recognized in earnings immediately. Ineffectiveness was not material in 2025, 2024 or 2023.
Derivatives not designated as hedging instruments
We also have foreign currency exposure on balances, primarily intercompany, that are denominated in a foreign currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in the Consolidated Statements of Earnings. To minimize foreign currency exposure, we have foreign currency contracts with notional amounts of $160,659 at September 27, 2025. The foreign currency contracts are recorded in the Consolidated Balance Sheets at fair value and resulting gains or losses are recorded in the Consolidated Statements of Earnings. We recorded the following gains and losses on foreign currency contracts which are included in other income or expense and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other income or expense:
| Statements of Earnings location | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Net gain | ||||
| Foreign currency contracts | Other | $2,211 | $5,121 | $2,781 |
Summary of derivatives
The fair value and classification of derivatives is summarized as follows:
| Balance Sheets location | September 27, 2025 | September 28, 2024 | |
|---|---|---|---|
| Derivatives designated as hedging instruments: | |||
| Foreign currency contracts | Other current assets | $250 | $— |
| Foreign currency contracts | Other assets | 39 | — |
| Total asset derivatives | $289 | $— | |
| Foreign currency contracts | Other long-term liabilities | 8 | — |
| Total liability derivatives | $8 | $— | |
| Derivatives not designated as hedging instruments: | |||
| Foreign currency contracts | Other current assets | $— | $648 |
| Foreign currency contracts | Accrued liabilities and other | $1,502 | $28 |
Note 13 -Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate fair value. The definition of the fair value hierarchy is as follows:
Level 1 – Quoted prices in active markets for identical assets and liabilities.
Level 2 – Observable inputs other than quoted prices in active markets for similar assets and liabilities.
Level 3 – Inputs for which significant valuation assumptions are unobservable in a market and therefore value is based on the best available data, some of which is internally developed and considers risk premiums that a market participant would require.
Our derivatives are valued using various pricing models or discounted cash flow analyses that incorporate observable market data, such as interest rate yield curves and currency rates, and are classified as Level 2 within the valuation hierarchy.
The following table presents the fair values and classification of our financial assets and liabilities measured on a recurring basis, all of which are classified as Level 2, except for the acquisition contingent consideration, which is classified as Level 3:
| Balance Sheets location | September 27, 2025 | September 28, 2024 | |
|---|---|---|---|
| Foreign currency contracts | Other current assets | $250 | $648 |
| Foreign currency contracts | Other assets | 39 | — |
| Total assets | $289 | $648 | |
| Foreign currency contracts | Accrued liabilities and other | $1,502 | $28 |
| Foreign currency contracts | Other long-term liabilities | 8 | — |
| Acquisition contingent consideration | Accrued liabilities and other | 473 | 2,839 |
| Total liabilities | $1,983 | $2,867 |
The changes in financial liabilities classified as Level 3 within the fair value hierarchy are as follows:
| Statements of Earnings location | September 27, 2025 | September 28, 2024 | |
|---|---|---|---|
| Balance at beginning of period | $2,839 | $3,089 | |
| Increase in discounted future cash flows | Interest expense | — | 237 |
| Increase (decrease) in earn out provisions | Other | 76 | (487) |
| Settlements paid in cash | (2,442) | — | |
| Balance at end of period | $473 | $2,839 |
Our only financial instrument for which the carrying value differs from its fair value is long-term debt. At September 27, 2025, the fair value of long-term debt was $932,570 compared to its carrying value of $946,000. The fair value of long-term debt is classified as Level 2 within the fair value hierarchy and was estimated based on quoted market prices.
Note 14 -Restructuring
In 2024, we initiated restructuring actions in relation to portfolio shaping activities. These actions have and will result in workforce reductions, principally in the U.S.and Europe. Total restructuring charges in 2024 include $11,096 for severance, $8,275 of non-cash charges related to intangibles, receivables, ROU assets and property and equipment written off and $4,417 for other costs.
In 2023, we initiated restructuring actions in relation to portfolio shaping activities. These actions have and will result in workforce reductions, principally in the U.S. and Europe. The 2023 restructuring charge consists of $6,905 for severance and $1,092 for facility closure and other costs. The 2023 plan has elements, primarily retention agreements, that will continue through 2027 and could result in additional costs of up to approximately $3,400.
Restructuring activity for severance and other costs by segment and reconciliation to consolidated amounts is as follows:
| Space and Defense | Military Aircraft | Commercial Aircraft | Industrial | Total | |
|---|---|---|---|---|---|
| Balance at October 1, 2022 | $228 | $229 | $— | $6,678 | $7,135 |
| Charged to expense - 2023 plan | 2,308 | 458 | — | 5,808 | 8,574 |
| Adjustments to provision | (37) | (15) | — | (525) | (577) |
| Cash payments - 2023 plan | (678) | (95) | — | (1,450) | (2,223) |
| Cash payments - 2022 plan | (190) | (229) | — | (1885) | (2,304) |
| Cash payments - 2020 plan | — | — | — | (372) | (372) |
| Cash payments - 2018 plan | — | — | — | (359) | (359) |
| Foreign currency translation | (9) | (1) | — | 313 | 303 |
| Balance at October 1, 2023 | 1,622 | 347 | — | 8,208 | 10,177 |
| Charged to expense - 2024 plan | 6,307 | 3,973 | 1,237 | 10,282 | 21,799 |
| Charged to expense - 2023 plan | — | — | — | 3,766 | 3,766 |
| Non-cash charges - 2024 plan | (4,907) | (733) | — | (2,635) | (8,275) |
| Adjustments to provision | (178) | (139) | — | (1,638) | (1,955) |
| Cash payments - 2024 plan | — | (2,616) | (477) | (3,740) | (6,833) |
| Cash payments - 2023 plan | (1444) | (208) | — | (4,014) | (5,666) |
| Cash payments - 2022 plan | — | — | — | (464) | (464) |
| Cash payments - 2020 plan | — | — | — | (485) | (485) |
| Cash payments - 2018 plan | — | — | — | (399) | (399) |
| Foreign currency translation | — | — | — | 513 | 513 |
| Balance at September 28, 2024 | 1,400 | 624 | 760 | 9,394 | 12,178 |
| Charged to expense - 2024 plan | 2,046 | — | — | 5,997 | 8,043 |
| Charged to expense - 2023 plan | — | — | — | 1,972 | 1,972 |
| Non-cash charges - 2024 plan | (448) | — | — | (732) | (1,180) |
| Adjustments to provision | — | — | — | (697) | (697) |
| Cash payments - 2024 plan | (871) | (624) | (760) | (7,953) | (10,208) |
| Cash payments - 2023 plan | — | — | — | (1,277) | (1,277) |
| Cash payments - 2022 plan | — | — | — | (32) | (32) |
| Cash payments - 2020 plan | — | — | — | (170) | (170) |
| Cash payments - 2018 plan | — | — | — | (400) | (400) |
| Foreign currency translation | 171 | — | — | 429 | 600 |
| Balance at September 27, 2025 | $2,298 | $— | $— | $6,531 | $8,829 |
As of September 27, 2025, the restructuring accrual consists $3,240 for the 2024 plan, $4,903 for the 2023 plan, $192 for the 2022 plan, $20 for the 2020 plan and $474 for the 2018 plan. Restructuring is expected to be paid within a year, except portions classified as long-term liabilities based on the nature of the reserve and the timing of the expected payments.
Note 15 -Employee Benefit Plans
We maintain multiple employee benefit plans, covering employees at certain locations.
Our qualified U.S. defined benefit pension plan is not open to new entrants. New employees are not eligible to participate in the pension plan. Instead, we make contributions for those employees to an employee-directed investment fund in the Moog Inc. Retirement Savings Plan ("RSP"), which consists of two defined contribution options, the RSP and the RSP(+). Effective January 1, 2020, all employees hired prior to January 1, 2019 are eligible to either participate in the new RSP(+) or remain in the existing RSP. All employees hired after January 1, 2019 are automatically enrolled in the new RSP(+). The Company’s contributions to both the RSP and RSP(+) are based on a percentage of the employee’s eligible compensation and age and are in addition to the employer match on voluntary employee contributions.
The RSP and RSP(+) includes an employee stock ownership feature. As one of the investment alternatives, participants in the RSP and RSP(+) can acquire our stock at market value. Shares are allocated and compensation expense is recognized as the employer share match is earned. At September 27, 2025, the participants in the RSP and RSP(+) owned 1,778,645 Class B shares.
Expense for all defined contribution plans consists of:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| U.S. defined contribution plans | $50,900 | $51,456 | $45,868 |
| Non-U.S. defined contribution plans | 10,699 | 9,993 | 8,650 |
| Total expense for defined contribution plans | $61,599 | $61,449 | $54,518 |
The changes in projected benefit obligations and plan assets and the funded status of the U.S. and non-U.S. defined benefit plans are as follows:
| U.S. Plans | Non-U.S. Plans | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Change in projected benefit obligation: | ||||
| Projected benefit obligation at prior year measurement date | $575,426 | $494,876 | $151,637 | $130,174 |
| Service cost | 9,881 | 10,775 | 3,087 | 2,580 |
| Interest cost | 26,897 | 27,891 | 5,307 | 5,720 |
| Contributions by plan participants | — | — | 165 | 170 |
| Actuarial (gains) losses | (25,562) | 62,473 | (8,581) | 12,198 |
| Foreign currency exchange impact | — | — | 3,134 | 7,737 |
| Benefits paid | (22,803) | (19,313) | (7,016) | (6,125) |
| Curtailments | — | — | — | (32) |
| Settlements | — | — | (892) | (565) |
| Other | (842) | (1,276) | (130) | (220) |
| Projected benefit obligation at measurement date | $562,997 | $575,426 | $146,711 | $151,637 |
| Change in plan assets: | ||||
| Fair value of assets at prior year measurement date | $472,633 | $392,444 | $113,776 | $97,184 |
| Actual return on plan assets | 22,105 | 94,443 | 760 | 9,883 |
| Employer contributions | 6,389 | 6,335 | (4,443) | 7,511 |
| Contributions by plan participants | — | — | 165 | 170 |
| Benefits paid | (22,803) | (19,313) | (7,016) | (6,125) |
| Settlements | — | — | (892) | (565) |
| Foreign currency exchange impact | — | — | 116 | 5,938 |
| Other | (842) | (1,276) | (130) | (220) |
| Fair value of assets at measurement date | $477,482 | $472,633 | $102,336 | $113,776 |
| Funded status and amount recognized in assets and liabilities | $(85,515) | $(102,793) | $(44,375) | $(37,861) |
| Amount recognized in assets and liabilities: | ||||
| Long-term assets | $— | $— | $15,254 | $15,640 |
| Current and long-term pension liabilities | (85,515) | (102,793) | (59,629) | (53,501) |
| Amount recognized in assets and liabilities | $(85,515) | $(102,793) | $(44,375) | $(37,861) |
| Amount recognized in AOCIL, before taxes: | ||||
| Prior service cost (credit) | $— | $— | $683 | $746 |
| Actuarial losses | 100,570 | 128,544 | 12,643 | 18,216 |
| Amount recognized in AOCIL, before taxes | $100,570 | $128,544 | $13,326 | $18,962 |
Our funding policy is to contribute at least the amount required by law in the respective countries.
The total accumulated benefit obligation as of the measurement date for all defined benefit pension plans was $676,061 in 2025 and $687,292 in 2024. At the measurement date in 2025, our plans had fair values of plan assets totaling $579,818. The following table provides aggregate information for the pension plans, which have accumulated benefit obligations in excess of plan assets:
| September 27, 2025 | September 28, 2024 | |
|---|---|---|
| Accumulated benefit obligation | $144,215 | $187,366 |
| Fair value of plan assets | 4,462 | 50,619 |
The following table provides aggregate information for the pension plans, which have projected benefit obligations in excess of plan assets:
| September 27, 2025 | September 28, 2024 | |
|---|---|---|
| Projected benefit obligation | $664,656 | $679,547 |
| Fair value of plan assets | 519,513 | 523,253 |
Weighted-average assumptions used to determine net periodic benefit cost and weighted-average assumptions used to determine benefit obligations as of the measurement dates are as follows:
| U.S. Plans | Non-U.S. Plans | |||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | 2025 | 2024 | 2023 | |
| Assumptions for net periodic benefit cost: | ||||||
| Service cost discount rate | 5.1% | 6.0% | 5.5% | 2.9% | 4.7% | 4.5% |
| Interest cost discount rate | 4.8% | 5.8% | 5.4% | 4.0% | 4.6% | 4.5% |
| Return on assets | 7.3% | 7.3% | 6.5% | 4.2% | 4.4% | 4.3% |
| Rate of compensation increase | 3.2% | 3.8% | 3.8% | 2.5% | 3.2% | 3.2% |
| Assumptions for benefit obligations: | ||||||
| Discount rate | 5.5% | 5.0% | 5.9% | 4.8% | 4.1% | 4.7% |
| Rate of compensation increase | 3.2% | 3.2% | 3.8% | 2.5% | 2.4% | 3.2% |
Pension plan investment policies and strategies are developed on a plan specific basis, which varies by country. The overall objective for the long-term expected return on both domestic and international plan assets is to earn a rate of return over time to meet anticipated benefit payments in accordance with plan provisions. The long-term investment objective of both the domestic and international retirement plans is to maintain the economic value of plan assets and future contributions by producing positive rates of investment return after subtracting inflation, benefit payments and expenses. Each of the plan’s strategic asset allocations is based on this long-term perspective and short-term fluctuations are viewed with appropriate perspective.
The U.S. qualified defined benefit plan’s assets are invested for long-term investment results. To accommodate the long-term investment horizon while providing appropriate liquidity, the plan maintains a liquid cash reserve sufficient to allow the plan to meet its benefit payment, fee and expense obligations. Its assets are broadly diversified to help alleviate the risk of adverse returns in any one security or investment class. The international plans’ assets are invested in both low-risk and high-risk investments in order to achieve the long-term investment strategy objective. Investment risks for both domestic and international plans are considered within the context of the entire asset allocation, rather than on a security-by-security basis.
The U.S. qualified defined benefit plan and certain international plans have investment committees that are responsible for formulating investment policies, developing manager guidelines and objectives and approving and managing qualified advisors and investment managers. The guidelines established for each of the plans define permitted investments within each asset class and apply certain restrictions such as limits on concentrated holdings in order to meet overall investment objectives.
Pension obligations and the related costs are determined using actuarial valuations that involve several assumptions. The return on assets assumption reflects the average rate of return expected on funds invested or to be invested to provide for the benefits included in the projected benefit obligation. In determining the return on assets assumption, we consider the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other indicators of future performance. Asset management objectives include maintaining an adequate level of diversification to reduce interest rate and market risk and to provide adequate liquidity to meet immediate and future benefit payment requirements.
In determining our U.S. pension expense for 2025, we assumed an average rate of return on U.S. pension assets of approximately 7.3% measured over a planning horizon with reasonable and acceptable levels of risk. The rate of return was based on the actual asset allocation of 41% in equity securities and 59% in fixed income securities at September 28, 2024. In determining our non-U.S. pension expense for 2025, we assumed an average rate of return on non-U.S. pension assets of approximately 4.2% measured over a planning horizon with reasonable and acceptable levels of risk.
The weighted average asset allocations by asset category for the pension plans as of September 27, 2025 and September 28, 2024 are as follows:
| U.S. Plans | Non-U.S. Plans | |||||
|---|---|---|---|---|---|---|
| Target | 2025Actual | 2024Actual | Target | 2025Actual | 2024Actual | |
| Asset category: | ||||||
| Equity | 47%-53% | 49% | 41% | 15%-35% | 24% | 26% |
| Fixed Income | 47%-53% | 51% | 59% | 30%-50% | 45% | 43% |
| Other | —% | —% | —% | 30%-40% | 31% | 31% |
The valuation methodologies used for pension plan assets measured at fair value have been applied consistently.
Shares of registered investment companies: Consists of both equity and fixed income mutual funds. Valued at quoted market prices that represent the net asset value ("NAV") of shares held by the plan at year end.
Equity securities: Traded on national exchanges are valued at the last reported sales price. Investments denominated in foreign currencies are translated into U.S. dollars using the last reported exchange rate.
Fixed income securities: Valued using methods, such as dealer quotes, available trade information, spreads, bids and offers provided by a pricing vendor.
Money market funds: Institutional short-term investment vehicles valued daily.
Cash and cash equivalents: Direct cash holdings valued at cost (Level 1) or cash collateral for the initial margin requirements on futures contracts (Level 2) which approximates fair value.
Collective investment trust: NAV of the fund is calculated daily or weekly by the investment manager.
Unit linked funds: NAV value of the fund is calculated daily by the investment manager.
Investment in insurance contracts: Valued at contract value, which is the fair value of the underlying investment of the insurance company.
Limited partnerships: Valued at NAV of units held. The NAV is used as a practical expedient to estimate fair value. The NAV is based on the fair value of the underlying investments held by the fund less its liability. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different from the reported NAV.
Securities or other assets for which market quotations are not readily available or for which market quotations do not represent the value at the time of pricing (including certain illiquid securities) are fair valued in accordance with procedures established under the supervision and responsibility of the Trustee of that investment. Such procedures may include the use of independent pricing services or affiliated advisor pricing, which use prices based upon yields or prices of securities of comparable quality, coupon, maturity and type, indications as to values from dealers, operating data and general market conditions.
The following tables present the consolidated plan assets using the fair value hierarchy, which is described in Note 13 - Fair Value, as of September 27, 2025 and September 28, 2024.
| U.S. Plans, September 27, 2025 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Investments at fair value: | ||||
| Money market funds | $— | $14,089 | $— | $14,089 |
| Cash and cash equivalents | — | 8,000 | — | 8,000 |
| Total investments in fair value hierarchy | — | 22,089 | — | 22,089 |
| Investments measured at NAV practical expedient (1) | 455,393 | |||
| Total investments at fair value | $— | $22,089 | $— | $477,482 |
| Non-U.S. Plans, September 27, 2025 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Investments at fair value: | ||||
| Mutual funds: | ||||
| Equity funds | $— | $2,474 | $— | $2,474 |
| Fixed income funds | — | 5,227 | — | 5,227 |
| Equity securities | 6,116 | — | — | 6,116 |
| Fixed income securities | — | 22,228 | — | 22,228 |
| Collective investment trusts | — | 23,012 | — | 23,012 |
| Unit linked funds | — | 14,417 | — | 14,417 |
| Money market funds | — | 496 | — | 496 |
| Cash and cash equivalents | 1,320 | — | — | 1,320 |
| Insurance contracts and other | — | — | 27,046 | 27,046 |
| Total investments at fair value | $7,436 | $67,854 | $27,046 | $102,336 |
| U.S. Plans, September 28, 2024 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Investments at fair value: | ||||
| Shares of registered investment companies: | ||||
| Equity funds | $181,871 | $— | $— | $181,871 |
| Fixed income funds | 153,575 | — | — | 153,575 |
| Money market funds | — | 7,834 | — | 7,834 |
| Cash and cash equivalents | — | 6,420 | — | 6,420 |
| Total investments in fair value hierarchy | 335,446 | 14,254 | — | 349,700 |
| Investments measured at NAV practical expedient (1) | 122,933 | |||
| Total investments at fair value | $335,446 | $14,254 | $— | $472,633 |
| Non-U.S. Plans, September 28, 2024 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Investments at fair value: | ||||
| Mutual funds: | ||||
| Equity funds | $— | $8,041 | $— | $8,041 |
| Fixed income funds | — | 7,626 | — | 7,626 |
| Equity securities | 6,970 | — | — | 6,970 |
| Fixed income securities | — | 23,263 | — | 23,263 |
| Collective investment trusts | — | 22,788 | — | 22,788 |
| Unit linked funds | — | 12,164 | — | 12,164 |
| Money market funds | — | 1,224 | — | 1,224 |
| Cash and cash equivalents | 1,102 | — | — | 1,102 |
| Insurance contracts and other | — | — | 30,598 | 30,598 |
| Total investments at fair value | $8,072 | $75,106 | $30,598 | $113,776 |
(1)Certain investments that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total retirement plan assets.
The following is a roll forward of the consolidated plan assets classified as Level 3 within the fair value hierarchy:
| Non-U.S. Plans | |
|---|---|
| Balance at September 30, 2023 | $1,618 |
| Return on assets | 31 |
| Purchases from contributions to Plans | 28,524 |
| Settlements paid in cash | (1,143) |
| Foreign currency translation | 1,568 |
| Balance at September 28, 2024 | 30,598 |
| Return on assets | (1,418) |
| Purchases from contributions to Plans | 1,164 |
| Settlements paid in cash | (3,075) |
| Foreign currency translation | (223) |
| Balance at September 27, 2025 | $27,046 |
The following table summarizes investments measured at fair value based on NAV per share as of September 27, 2025:
| Fair Value | |||||
|---|---|---|---|---|---|
| September 27, 2025 | September 28, 2024 | Unfunded Commitments | Redemption Frequency | Redemption Notice Period | |
| Collective investment trusts | $446,595 | $111,831 | $— | Daily | 1-5 days |
| Limited partnerships (1) | 8,798 | 11,102 | 3,273 | Varies | 10-45 days |
| Total | $455,393 | $122,933 | $3,273 | ||
(1)Investments in limited partnerships held by us invest primarily in emerging markets, equity and equity related securities. The strategy for the partnerships is to have exposure to certain markets or to securities that are judged to achieve superior earnings growth and/or judged undervalued relative to intrinsic value.
The preceding methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although we believe the valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
Expense for defined benefit plans is as follows:
| U.S. Plans | Non-U.S. Plans | |||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | 2025 | 2024 | 2023 | |
| Service cost | $9,881 | $10,775 | $12,913 | $3,087 | $2,580 | $2,674 |
| Interest cost | 26,897 | 27,891 | 28,112 | 5,307 | 5,720 | 5,448 |
| Expected return on plan assets | (31,601) | (27,267) | (28,589) | (4,193) | (4,420) | (4,244) |
| Amortization of prior service cost | — | — | — | 58 | 57 | 55 |
| Amortization of actuarial loss | 11,908 | 12,289 | 13,449 | 778 | 209 | 399 |
| Settlement (gain) loss | — | — | 12,542 | (129) | (77) | (151) |
| Total expense for defined benefit plans | $17,085 | $23,688 | $38,427 | $4,908 | $4,069 | $4,181 |
Benefits expected to be paid to the participants of the plans are:
| U.S. Plans · Non-U.S. Plans | ||
|---|---|---|
| 2026 | $24,959 | $7,766 |
| 2027 | 27,607 | 7,643 |
| 2028 | 30,247 | 8,965 |
| 2029 | 33,786 | 9,044 |
| 2030 | 36,178 | 9,010 |
| Five years thereafter | 201,660 | 45,850 |
We presently anticipate contributing approximately $5,700 to the SERP Trust for the non-qualified plan and $4,500 to the non-U.S. plans in 2026.
We provide postretirement health care benefits to certain domestic retirees, who were hired prior to October 1, 1989. There areno plan assets. The changes in the accumulated benefit obligation of this unfunded plan for 2025 and 2024 are shown in the following table:
| September 27, 2025 | September 28, 2024 | |
|---|---|---|
| Change in Accumulated Postretirement Benefit Obligation (APBO): | ||
| APBO at prior year measurement date | $2,253 | $2,840 |
| Service cost | 6 | 11 |
| Interest cost | 88 | 144 |
| Contributions by plan participants | 328 | 382 |
| Benefits paid | (828) | (798) |
| Actuarial (gains) losses | (36) | (326) |
| APBO at measurement date | $1,811 | $2,253 |
| Funded status | $(1,811) | $(2,253) |
| Accrued postretirement benefit liability | $1,811 | $2,253 |
| Amount recognized in AOCIL, before taxes: | ||
| Actuarial gains | 2,362 | 3,717 |
| Amount recognized in AOCIL, before taxes | $2,362 | $3,717 |
The cost of the postretirement benefit plan is as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Service cost | $6 | $11 | $16 |
| Interest cost | 88 | 144 | 166 |
| Amortization of actuarial gain | (1,391) | (1,861) | (2,321) |
| Net periodic postretirement benefit income | $(1,297) | $(1,706) | $(2,139) |
As of the measurement date, the assumed discount rate used in the accounting for the postretirement benefit obligation was 4.7% in 2025,4.5% in 2024 and 5.6% in 2023. The assumed service cost discount rate and interest cost discount rate used in the accounting for the net periodic postretirement benefit cost were 4.3% and 4.4%, respectively in 2025,5.4% and 5.7%, respectively in 2024 and 5.1% and 5.1%, respectively in 2023.
For measurement purposes, a 8.0% annual per capita rate of increase of medical and drug costs were assumed for 2026, gradually decreasing to 4.5% for 2035 and years thereafter.
Employee and management profit sharing reflects a discretionary payment based on our financial performance. Profit share expense was $52,100, $46,424 and $38,702 in 2025, 2024 and 2023, respectively.
Note 16 -Income Taxes
The reconciliation of the provision for income taxes to the amount computed by applying the U.S. federal statutory tax rate to earnings before income taxes is as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Earnings before income taxes: | |||
| Domestic | $167,179 | $186,376 | $140,708 |
| Foreign | 145,469 | 83,370 | 80,812 |
| Total | $312,648 | $269,746 | $221,520 |
| Federal statutory income tax rate | 21.0% | 21.0% | 21.0% |
| Increase (decrease) in income taxes resulting from: | |||
| Impacts of Tax Act | 0.2% | (1.2)% | (0.7)% |
| Tax on foreign earnings | 1.3% | 0.8% | 0.9% |
| R&D and foreign tax credits | (3.8)% | (4.3)% | (6.2)% |
| Divestiture impacts | 0.4% | 0.5% | —% |
| Foreign tax rates | 3.8% | 2.7% | 6.6% |
| Equity-based compensation and benefits | —% | 0.2% | 0.5% |
| Unrecognized tax benefits | —% | —% | (0.5)% |
| Change in valuation allowance for deferred taxes | 0.5% | 1.7% | (0.8)% |
| State taxes, net of federal benefit | 0.5% | 0.8% | 0.2% |
| Other | 0.9% | 0.4% | (0.1)% |
| Effective income tax rate | 24.8% | 22.6% | 20.9% |
Our accounting policy is to treat tax on the Global Intangible Low-Tax Income ("GILTI") as a current period cost included in tax expense the year incurred. As such, we don't measure the impact of the GILTI in our determination of deferred taxes.
During 2025, 2024 and 2023, we repatriated available unremitted earnings from various foreign subsidiaries that were previously taxed of $111,646, $37,259 and $39,156, respectively. We do not assert indefinite reinvestment on unremitted earnings and therefore we record a liability related to the remaining unremitted earnings generated by the foreign subsidiaries. As of September 27, 2025, we have recorded a deferred tax liability of $9,305, which represents the future tax consequences upon ultimate repatriation of the unremitted earnings. We continue to be permanently reinvested in outside basis differences other than the unremitted earnings as we have no plans to liquidate or sell those foreign subsidiaries. In addition, we have not provided for deferred taxes on any outside basis differences of our domestic subsidiaries as we have the ability and intent to recover these basis differences in a tax-free manner. It is not practicable to determine the amount of unrecognized deferred tax related to these basis differences.
The components of income taxes are as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current: | |||
| Federal | $30,351 | $50,813 | $42,289 |
| Foreign | 48,018 | 31,210 | 32,374 |
| State | 5,795 | 8,588 | 6,696 |
| Total current | 84,164 | 90,611 | 81,359 |
| Deferred: | |||
| Federal | (10,142) | (29,268) | (30,344) |
| Foreign | 4,197 | 2,589 | 686 |
| State | (599) | (2,972) | (5,337) |
| Total deferred | (6,544) | (29,651) | (34,995) |
| Income taxes | $77,620 | $60,960 | $46,364 |
Realization of deferred tax assets is dependent, in part, upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers projected future taxable income, tax planning strategies, carryback opportunities and reversal of existing deferred tax liabilities in making its assessment of the recoverability of deferred tax assets.
The tax effects of temporary differences that generated deferred tax assets and liabilities are as follows:
| September 27,2025 | September 28,2024 | |
|---|---|---|
| Deferred tax assets: | ||
| Research and development | $86,109 | $64,530 |
| Benefit accruals | 46,669 | 54,667 |
| Inventory reserves | 28,139 | 28,435 |
| Tax benefit carryforwards | 13,180 | 18,034 |
| Contract reserves not currently deductible | 18,713 | 18,169 |
| Lease liability | 15,756 | 16,191 |
| Other accrued expenses | — | 2,835 |
| Total gross deferred tax assets | 208,566 | 202,861 |
| Less valuation allowance | (12,317) | (10,905) |
| Total net deferred tax assets | $196,249 | $191,956 |
| Deferred tax liabilities: | ||
| Differences in bases and depreciation of property, plant and equipment | $189,878 | $178,868 |
| Pension | 14,881 | 16,856 |
| Other | 1,631 | — |
| Total gross deferred tax liabilities | 206,390 | 195,724 |
| Net deferred tax liabilities | $(10,141) | $(3,768) |
Deferred tax assets and liabilities are reported in separate captions on the Consolidated Balance Sheets.
At September 27, 2025, we have $506 of federal tax credit carryforward with expirations of 2033 and 2034 and $10,403 state tax credit carryforward with expirations of 2027 to indefinite life. The change in the valuation allowance primarily relates to tax benefit carryforwards that were generated in 2025 but not expected to be realized.
We record unrecognized tax benefits as liabilities and we adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Further, we record interest and penalties related to unrecognized tax benefits in income tax expense. During the period ended September 30, 2023, we recorded a $1,072 benefit for the reversal of our uncertain tax positions as a result of updated guidance. As of September 28, 2024 and September 27, 2025 we haveno uncertain tax positions.
We are subject to income taxes in the U.S. and in various states and foreign jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require the application of judgment. With few exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities in significant jurisdictions for tax years before 2022. The statute of limitations in several jurisdictions will expire in the next twelve months and we will haveno unrecognized tax benefits recognized if the statute of limitations expires without the relevant taxing authority examining the applicable returns.
During October 2021, the Organization for Economic Cooperation and Development ("OECD") passed Pillar Two, an inclusive framework on Base Erosion and Profit Sharing, which would enact a minimum 15% tax for large multinational companies. Many countries are considering changes to their tax laws or proposing new tax laws to align with the recommendations that have been made by the OECD regarding Pillar Two. The Company is closely monitoring developments and evaluating the potential impacts that Pillar Two will have on future periods, including the qualification for safe harbor. As of September 27, 2025, the Company has not recorded a material top-up tax related to Pillar Two.
On July 4, 2025, the One Big Beautiful Bill Act (the "Act") was signed into law. The legislation includes a broad range of tax reform provisions affecting businesses including, but not limited to, the expansion of bonus depreciation, immediate expensing of domestic R&D costs, and revisions to the U.S. taxation of profits derived from international operations. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Act allowed the Company to take 100% tax deduction on certain fixed assets that were placed in service after January 19, 2025. Other than accelerated tax depreciation, the Act did not have a material impact on the Company financial position and results of operations as of and for the year ended September 27, 2025.
Note 17 -Earnings per Share
Basic and diluted weighted-average shares outstanding, as well as shares considered to be anti-dilutive, are as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Basic weighted-average shares outstanding | 31,680,280 | 31,954,689 | 31,831,687 |
| Dilutive effect of equity-based awards | 402,321 | 404,649 | 212,539 |
| Diluted weighted-average shares outstanding | 32,082,601 | 32,359,338 | 32,044,226 |
Note 18 -Shareholders’ Equity
Class A and Class B common stock share equally in our earnings and are identical with certain exceptions. Other than on matters relating to the election of directors or as required by law where the holders of Class A and Class B shares vote as separate classes, Class A shares have limited voting rights, with each share of Class A being entitled toone-tenth of a vote on most matters, and each share of Class B being entitled toone vote. Class A shareholders are entitled, subject to certain limitations, to elect at least 25% of the Board of Directors (rounded up to the nearest whole number) with Class B shareholders entitled to elect the balance of the directors. No cash dividend may be paid on Class B shares unless at least an equal cash dividend is paid on Class A shares. Class B shares are convertible at any time into Class A shares on aone-for-one basis at the option of the shareholder.
Class A shares and Class B shares reserved for issuance at September 27, 2025 are as follows:
| Shares | |
|---|---|
| Conversion of Class B to Class A shares | 7,416,255 |
| Employee Stock Purchase Plan | 1,073,204 |
| 2025 Long Term Incentive Plan | 1,500,000 |
| 2014 Long Term Incentive Plan | 1,503,804 |
| 2008 Stock Appreciation Rights Plan | 979,995 |
| Class A and B shares reserved for issuance | 12,473,258 |
We are authorized to issue up to 10,000,000 shares of preferred stock. The Board of Directors may authorize, without further shareholder action, the issuance of additional preferred stock which ranks senior to both classes of our common stock with respect to the payment of dividends and the distribution of assets on liquidation. The preferred stock, when issued, would have such designations relative to voting and conversion rights, preferences, privileges and limitations as determined by the Board of Directors.
We issue common stock under our equity-based compensation plans from treasury stock or from stock held by the SECT. As of September 27, 2025, in addition to the shares reserved for issuance upon the exercise of outstanding equity awards, there were 1,458,225 shares authorized for awards that may be granted in the future under the 2025 Long Term Incentive Plan, assuming performance-based awards currently outstanding are all settled at the targeted payout.
On November 20, 2020, the Board of Directors authorized a new share repurchase program to replace the previously existing share repurchase program. This program authorizes repurchases that includes both Class A and Class B common stock, and allows us to buy up to an aggregate 3,000,000 common shares. Shares acquired by the SECT or the SERP Trust are not included in this program. During 2025, we repurchased 511,974 of our Class A and B common stock for $100,705. During 2024, there wereno repurchases of our Class A and B common stock. During 2023, we repurchased 97,849 of our Class A and B common stock for $7,697. As of September 27, 2025, the total remaining authorization for future common share repurchases under our program is 1,660,107 shares.
Note 19 -Equity-Based Compensation
We have equity-based compensation plans that authorize the issuance of equity-based awards for shares of Class A and Class B common stock to directors, officers and key employees. Equity-based compensation grants are designed to reward long-term contributions to Moog and provide incentives for recipients to remain with Moog.
We have an Employee Stock Purchase Plan ("ESPP") that allows for qualified employees (as defined in the plan) to purchase our common stock at a price equal to 85% of the fair market value at the lower of the beginning or the end of the semi-annual offering period.
The 2014 Long Term Incentive Plan ("2014 Plan") authorizes the issuance of a total of 2,000,000 shares of either Class A or Class B common stock. The 2014 Plan is intended to provide a flexible framework that permits the development and implementation of a variety of equity-based programs that base awards on key performance metrics as well as align our long term incentive compensation with our peers and shareholder interests. The LTI awards granted in 2025 were granted pursuant the terms of the 2014 Plan.
In February 2025, the 2025 LTI Plan ("2025 Plan") was approved by shareholders, providing for the grant of awards covering 1,500,000 Class A or Class B shares of stock. The 2025 Plan was implemented to provide a flexible framework that permits the development and implementation of a variety of stock-based programs based on the changing needs of Moog, its competitive market and the regulatory climate. The 2025 Plan is a successor to the 2014 Plan. No additional grants shall be made under the 2014 Plan on and after the effective date of the 2025 Plan. Outstanding awards granted under the 2014 Plan continue in effect according to their terms.
During 2025, we granted awards in the form of performance-based restricted stock units ("PSUs"), time vested restricted stock units ("TVAs") and restricted stock awards ("RSAs"). The compensation cost for employee and non-employee director equity-based compensation programs for all current and prior year awards granted are as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Performance-based restricted stock units | $6,740 | $5,994 | $2,479 |
| Employee stock purchase plan | 4,761 | 3,718 | 2,956 |
| Time vested restricted stock units | 3,994 | 3,223 | 2,461 |
| Restricted stock awards | 1,126 | 1,151 | 1,102 |
| Stock appreciation rights | 88 | 872 | 1,584 |
| Total compensation cost before income taxes | $16,709 | $14,958 | $10,582 |
| Income tax benefit | $1,417 | $2,091 | $1,156 |
Restricted Stock Units
Performance-Based Awards
PSU awards consist of shares of our stock which are payable upon the determination that we achieve certain established performance targets and can range from 0% to 200% of the targeted payout based on the actual results. PSU's granted in 2025 have a performance period ofthree years. The fair value of each PSU granted is equal to the fair market value of our common stock on the date of grant. PSUs granted generally have a cliff vesting schedule ofthree years; however, according to the grant agreements, if certain conditions are met, the employee (or beneficiary) may receive an amount of the award based on the terms and conditions of the agreement.
PSUs are as follows:
| Performance-Based Restricted Stock Units | Number of Awards | Weighted-AverageGrant Date Fair Value |
|---|---|---|
| Nonvested at September 28, 2024 | 76,771 | $105.67 |
| Granted in 2025 | 25,728 | 207.10 |
| Vested in 2025 | (38,596) | 86.97 |
| Forfeited in 2025 | (2,973) | 111.02 |
| Nonvested at September 27, 2025 | 60,930 | $160.08 |
As of September 27, 2025, total unvested compensation expense associated with nonvested PSUs amounted to$5,201 and will be recognized over a weighted-average period oftwo years.
The number of Class B shares to be issued for PSU awards granted in 2023 that vested based on the achievement of performance targets in 2025, will be approximately 57,600 shares.
Time Vested Awards
TVAs consist of shares of our stock which are payable over a vesting schedule determined at the time the award is granted. TVAs vest in equal fixed dollar tranches over the agreed upon vesting term beginningone year after the date of the grant and will settle using the fair market value of shares on the date of vesting of the tranche. Although it is our intention to settle vested amount in shares, we reserve the right to settle in cash at our discretion.
TVAs are as follows:
| Time Vested Restricted Stock Units | Number of Awards | Weighted-AverageFair Value |
|---|---|---|
| Nonvested at September 28, 2024 | 39,113 | $198.29 |
| Granted in 2025 | 24,659 | 207.10 |
| Vested in 2025 | (15,947) | 214.03 |
| Forfeited in 2025 | (2,674) | 173.99 |
| Decrease due to fair value change in 2025 | (1,446) | n/a |
| Nonvested at September 27, 2025 | 43,705 | $206.00 |
As of September 27, 2025, total unvested compensation expense associated with nonvested TVAs amounted to $5,559 and will be recognized over a weighted-average period oftwo years.
The number of Class B shares to be issued for TVAs that are expected to vest in 2025 from time based service conditions is approximately 16,200 shares, based on our closing price of Class B common stock of $206.00 as of September 27, 2025.
Restricted Stock Awards
The fair value of each RSA granted is equal to the fair market value of our common stock on the date of grant. These shares vest and are issued upon grant. There were 5,436 RSAs granted and vested in 2025 at a price of $207.10 resulting in a fair value of the RSAs vested of $1,126.
Employee Stock Purchase Plan
Shares and the weighted-average price per share associated with the ESPP are as follows:
| Employee Stock Purchase Plan | 2025 | 2024 | 2023 |
|---|---|---|---|
| Shares issued | 110,984 | 126,355 | 155,704 |
| Weighted-average price per share | $147.97 | $105.18 | $70.91 |
Stock Appreciation Rights
The fair value of SARs granted was estimated on the date of grant using the Black-Scholes option-pricing model. In 2025, there wereno SARs granted. The number of shares received upon the exercise of a SAR is equal in value to the difference between the fair market value of the common stock on the exercise date and the exercise price of the SAR. The term of a SAR may not exceed ten years from the grant date. The exercise price of SARs and options, determined by a committee of the Board of Directors, may not be less than the fair value of the common stock on the grant date.
SARs are as follows:
| Stock Appreciation Rights | Number of Awards | Weighted-AverageExercise Price | Weighted-AverageRemaining Contractual Life | AggregateIntrinsicValue |
|---|---|---|---|---|
| Outstanding at September 28, 2024 | 550,018 | $78.18 | ||
| Exercised in 2025 | (80,252) | 72.44 | ||
| Forfeited in 2025 | (165) | 83.00 | ||
| Outstanding at September 27, 2025 | 469,601 | $79.16 | 3.44 | $59,547 |
| Exercisable at September 27, 2025 | 469,601 | $79.16 | 3.44 | $59,547 |
The aggregate intrinsic value in the preceding tables represents the total pre-tax intrinsic value, based on our closing price of Class A common stock of $204.64 and Class B common stock of $206.00 as of September 27, 2025. That value would have been effectively received by the SAR holders had all SARs been exercised as of that date.
The intrinsic value of awards exercised and fair value of awards vested are as follows:
| Stock Appreciation Rights | 2025 | 2024 | 2023 |
|---|---|---|---|
| Intrinsic value of SARs exercised | $10,230 | $13,413 | $5,596 |
| Total fair value of SARs vested | $741 | $1,511 | $2,426 |
As of September 27, 2025, there isno unvested compensation expense associated with SARs.
Note 20 -Stock Employee Compensation Trust and Supplemental Retirement Plan Trust
The SECT assists in administering and provides funding for equity-based compensation plans and benefit programs, including the Moog Inc. Retirement Savings Plan ("RSP"), RSP(+) and the Employee Stock Purchase Plan ("ESPP"). The SERP Trust provides funding for benefits under the SERP provisions of the Moog Inc. Plan to Equalize Retirement Income and Supplemental Retirement Income. Both the SECT and the SERP Trust hold Moog shares as investments. The shares in the SECT and SERP Trust are not considered outstanding for purposes of calculating earnings per share. However, in accordance with the trust agreements governing the SECT and SERP Trust, the trustees vote all shares held by the SECT and SERP Trust on all matters submitted to shareholders.
Note 21 -Accumulated Other Comprehensive Income (Loss)
The changes in AOCIL, net of tax, by component are as follows:
| Accumulated foreign currency translation | Accumulated retirement liability | Accumulated gain (loss) on derivatives | Total | |
|---|---|---|---|---|
| AOCIL at September 30, 2023 | $(140,477) | $(113,605) | $(518) | $(254,600) |
| OCI before reclassifications | 44,966 | (1,811) | 69 | 43,224 |
| Amounts reclassified from AOCIL | (11) | 8,126 | 449 | 8,564 |
| OCI, net of tax | 44,955 | 6,315 | 518 | 51,788 |
| AOCIL at September 28, 2024 | (95,522) | (107,290) | — | (202,812) |
| OCI before reclassifications | 8,252 | 15,334 | 617 | 24,203 |
| Amounts reclassified from AOCIL | 12,656 | 8,644 | (410) | 20,890 |
| OCI, net of tax | 20,908 | 23,978 | 207 | 45,093 |
| AOCIL at September 27, 2025 | $(74,614) | $(83,312) | $207 | $(157,719) |
Net gains and losses on net investment hedges are recorded in Accumulated foreign currency translation to the extent that the instruments are effective in hedging the designated risk.
The amounts reclassified from AOCIL into earnings are as follows:
| Statements of Earnings location · 2025 · 2024 | ||||
|---|---|---|---|---|
| Retirement liability: | ||||
| Prior service cost | $58 | $57 | ||
| Actuarial losses | 11,295 | 10,637 | ||
| Settlement loss | (129) | (77) | ||
| Reclassification from AOCIL into earnings | 11,224 | 10,617 | ||
| Tax effect | (2,580) | (2,491) | ||
| Net reclassification from AOCIL into earnings | $8,644 | $8,126 | ||
| Derivatives: | ||||
| Foreign currency contracts | Cost of sales | $(536) | $588 | |
| Reclassification from AOCIL into earnings | (536) | 588 | ||
| Tax effect | 126 | (139) | ||
| Net reclassification from AOCIL into earnings | $(410) | $449 | ||
| Foreign currency translation: | ||||
| Business dispositions | Other | $12,656 | $(11) | |
| Reclassification from AOCIL into earnings | 12,656 | (11) | ||
| Tax effect | — | — | ||
| Net reclassification from AOCIL into earnings | $12,656 | $(11) | ||
Reclassification from AOCIL into earnings for the Retirement liability are included in the computation of non-service pension expense, which is included in Other and Pension settlement on the Consolidated Statements of Earnings
The effective portion of amounts deferred in AOCIL are as follows:
| 2025 | 2024 | |
|---|---|---|
| Retirement liability: | ||
| Net actuarial gain (loss) during period | $20,190 | $(1,546) |
| Tax effect | (4,856) | (265) |
| Net deferral in AOCIL of retirement liability | $15,334 | $(1,811) |
| Derivatives: | ||
| Foreign currency contracts | $807 | $90 |
| Net gain | 807 | 90 |
| Tax effect | (190) | (21) |
| Net deferral in AOCIL of derivatives | $617 | $69 |
Note 22 -Segments
Space and Defense. We manufacture critical defense components and motion-control systems used in defense vehicle platforms, missile systems, naval ships and submarines. We also manufacture high-performance components and systems used for space launch vehicles, satellites and spacecraft vehicles.
Military Aircraft. We design, manufacture and integrate primary and secondary flight controls, mission-critical actuation systems, and products for various military fixed-wing aircraft and rotorcraft for both OEM and aftermarket customers.
Our military production programs include the F-35 Joint Strike Fighter and we are currently working on the development of the Textron Bell MV-75 and other classified funded development military programs.
Aftermarket sales, which represented 23%,23% and 26% of 2025, 2024 and 2023 sales, respectively, consist of the maintenance, upgrades, spares, repairs and overhauls for military depots and existing fleets.
Commercial Aircraft. We design, manufacture and integrate primary and secondary flight-critical control systems and products for various commercial aircraft including widebody, narrowbody, business jets and regional jets for both OEM and aftermarket customers.
Our large commercial production programs include the Boeing 787 and the Airbus A350 programs. Our additional production programs include the Boeing 737 MAX, the Airbus A320 and A330, the Embraer E195-E2 and various Gulfstream business jets.
Aftermarket sales, which represented 37%,33% and 34% of 2025, 2024 and 2023 sales, respectively, consist of support for the maintenance, upgrades, spares, repairs and overhauls for aircraft operators worldwide.
Industrial. We provide customized, high-performance motion control components and systems for industrial automation, medical, simulation and test and energy applications.
Our offerings include precision components used in heavy machinery, medical devices and components, power generation products, as well as simulation platforms for flight training and material testing applications.
Disaggregation of net sales by segment are as follows:
| Market Type | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net sales: | |||
| Space | $474,517 | $434,936 | $407,009 |
| Defense | 638,511 | 583,212 | 540,242 |
| Space and Defense | 1,113,028 | 1,018,148 | 947,251 |
| Original Equipment Manufacturers | 687,261 | 624,575 | 536,562 |
| Aftermarket | 200,875 | 186,991 | 183,770 |
| Military Aircraft | 888,136 | 811,566 | 720,332 |
| Original Equipment Manufacturers | 572,971 | 524,699 | 431,521 |
| Aftermarket | 330,908 | 263,401 | 234,362 |
| Commercial Aircraft | 903,879 | 788,100 | 665,883 |
| Energy | 141,679 | 137,854 | 123,864 |
| Industrial Automation | 401,697 | 443,580 | 485,502 |
| Simulation and Test | 141,551 | 155,889 | 124,980 |
| Medical | 270,654 | 253,823 | 248,378 |
| Industrial | 955,581 | 991,146 | 982,724 |
| Net sales | $3,860,624 | $3,608,960 | $3,316,190 |
| Customer Type | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net sales: | |||
| Commercial | $187,528 | $172,829 | $112,777 |
| U.S. Government (including OEM) | 798,956 | 754,057 | 778,229 |
| Other | 126,544 | 91,262 | 56,245 |
| Space and Defense | 1,113,028 | 1,018,148 | 947,251 |
| U.S. Government (including OEM) | 657,813 | 582,688 | 505,794 |
| Other | 230,323 | 228,878 | 214,538 |
| Military Aircraft | 888,136 | 811,566 | 720,332 |
| Commercial | 853,045 | 751,110 | 632,878 |
| Other | 50,834 | 36,990 | 33,005 |
| Commercial Aircraft | 903,879 | 788,100 | 665,883 |
| Commercial | 933,664 | 971,868 | 965,867 |
| U.S. Government (including OEM) | 4,648 | 10,438 | 5,204 |
| Other | 17,269 | 8,840 | 11,653 |
| Industrial | 955,581 | 991,146 | 982,724 |
| Commercial | 1,974,237 | 1,895,807 | 1,711,522 |
| U.S. Government (including OEM) | 1,461,417 | 1,347,183 | 1,289,227 |
| Other | 424,970 | 365,970 | 315,441 |
| Net sales | $3,860,624 | $3,608,960 | $3,316,190 |
| Revenue Recognition Method | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net sales: | |||
| Over-time | $997,351 | $909,638 | $883,727 |
| Point in time | 115,677 | 108,510 | 63,524 |
| Space and Defense | 1,113,028 | 1,018,148 | 947,251 |
| Over-time | 732,837 | 656,576 | 602,333 |
| Point in time | 155,299 | 154,990 | 117,999 |
| Military Aircraft | 888,136 | 811,566 | 720,332 |
| Over-time | 636,760 | 587,233 | 497,221 |
| Point in time | 267,119 | 200,867 | 168,662 |
| Commercial Aircraft | 903,879 | 788,100 | 665,883 |
| Over-time | 114,699 | 142,425 | 137,338 |
| Point in time | 840,882 | 848,721 | 845,386 |
| Industrial | 955,581 | 991,146 | 982,724 |
| Over-time | 2,481,647 | 2,295,872 | 2,120,619 |
| Point in time | 1,378,977 | 1,313,088 | 1,195,571 |
| Net sales | $3,860,624 | $3,608,960 | $3,316,190 |
Sales to Boeing were $396,784, $417,275 and $349,961, or 10%,12% and 11% of sales, in 2025, 2024 and 2023, respectively. Sales arising from U.S. Government prime or sub-contracts, including military sales to Boeing are made primarily from our Military Aircraft and Space and Defense segments and are included in the Customer Type table above.
The Company’s Chief Operating Decision Maker (“CODM”) is the President and Chief Executive Officer. The CODM is responsible for allocating resources and assessing performance based on the segment’s operating profit or loss, among other considerations. Segment operating profit is net sales less cost of sales and other operating expenses, excluding interest expense, equity-based compensation, non-service pension expense and other corporate expenses. Cost of sales and other operating expenses are directly attributable to the respective segment or allocated on the basis of sales, headcount or profit.
We report results to our CODM under our four segments identified as Space and Defense, Military Aircraft, Commercial Aircraft and Industrial. Disaggregation of operating results by segment and reconciliations to consolidated amounts are as follows:
| Fiscal Year Ended | |||
|---|---|---|---|
| (dollars in thousands) | September 27, 2025 | September 28, 2024 | September 30, 2023 |
| Net sales: | |||
| Space and Defense | $1,113,028 | $1,018,148 | $947,251 |
| Military Aircraft | 888,136 | 811,566 | 720,332 |
| Commercial Aircraft | 903,879 | 788,100 | 665,883 |
| Industrial | 955,581 | 991,146 | 982,724 |
| Total net sales | $3,860,624 | $3,608,960 | $3,316,190 |
| Cost of sales: | |||
| Space and Defense | $800,982 | $734,844 | $718,545 |
| Military Aircraft | 656,054 | 604,285 | 552,268 |
| Commercial Aircraft | 720,296 | 617,858 | 505,884 |
| Industrial | 617,470 | 632,538 | 637,393 |
| Total cost of sales | $2,794,802 | $2,589,525 | $2,414,090 |
| Inventory write-down: | |||
| Space and Defense | $939 | $1,918 | $— |
| Military Aircraft | 1,625 | 175 | 1,616 |
| Commercial Aircraft | — | — | — |
| Industrial | 5,910 | 4,934 | 2,729 |
| Total inventory write-down | $8,474 | $7,027 | $4,345 |
| Research and development: | |||
| Space and Defense | $25,511 | $26,084 | $16,736 |
| Military Aircraft | 24,549 | 23,475 | 33,941 |
| Commercial Aircraft | 7,798 | 11,930 | 9,485 |
| Industrial | 35,813 | 51,284 | 46,389 |
| Total research and development | $93,671 | $112,773 | $106,551 |
| Selling, general and administrative: | |||
| Space and Defense | $152,820 | $122,568 | $112,426 |
| Military Aircraft | 108,902 | 89,779 | 70,882 |
| Commercial Aircraft | 65,605 | 59,170 | 65,700 |
| Industrial | 176,363 | 182,005 | 189,511 |
| Selling, general and administrative for reportable segments | $503,690 | $453,522 | $438,519 |
| Corporate expenses | 33,570 | 32,772 | 25,836 |
| Equity based compensation expense | 16,708 | 14,959 | 10,582 |
| Total selling, general and administrative | $553,968 | $501,253 | $474,937 |
| Other operating (income) expenses: | |||
| Space and Defense | $1,639 | $5,849 | $3,437 |
| Military Aircraft | (1,751) | 8,349 | 1,000 |
| Commercial Aircraft | (1,613) | 265 | (1,223) |
| Industrial | 12,106 | 27,185 | 5,433 |
| Total other operating expenses | $10,381 | $41,648 | $8,647 |
Other segment operating income and expenses include restructuring, asset impairments, fair value adjustments, gains or losses on business disposals, royalty income and miscellaneous income and expenses.
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating profit: | |||
| Space and Defense | $131,137 | $126,885 | $96,107 |
| Military Aircraft | 98,757 | 85,503 | 60,625 |
| Commercial Aircraft | 111,793 | 98,877 | 86,037 |
| Industrial | 107,919 | 93,200 | 101,269 |
| Total operating profit | 449,606 | 404,465 | 344,038 |
| Deductions from operating profit: | |||
| Interest expense | 72,075 | 66,330 | 59,838 |
| Equity-based compensation expense | 16,708 | 14,959 | 10,582 |
| Pension settlement | — | — | 12,542 |
| Non-service pension expense | 7,719 | 12,685 | 12,324 |
| Corporate and other expenses, net | 40,456 | 40,745 | 27,232 |
| Earnings before income taxes | $312,648 | $269,746 | $221,520 |
| Depreciation and amortization: | |||
| Space and Defense | $24,937 | $21,895 | $20,067 |
| Military Aircraft | 34,424 | 31,327 | 30,449 |
| Commercial Aircraft | 18,780 | 16,116 | 12,678 |
| Industrial | 25,420 | 26,482 | 25,897 |
| Corporate | 167 | 207 | 213 |
| Total depreciation and amortization | $103,728 | $96,027 | $89,304 |
| Identifiable assets: | |||
| Space and Defense | $1,213,618 | $1,035,716 | $1,011,724 |
| Military Aircraft | 1,041,046 | 961,056 | 866,590 |
| Commercial Aircraft | 1,052,419 | 953,053 | 779,949 |
| Industrial | 1,102,533 | 1,098,953 | 1,086,818 |
| Corporate | 16,439 | 28,869 | 23,266 |
| Total assets | $4,426,055 | $4,077,647 | $3,768,347 |
| Capital expenditures: | |||
| Space and Defense | $59,162 | $47,170 | $66,613 |
| Military Aircraft | 37,422 | 52,741 | 47,699 |
| Commercial Aircraft | 23,283 | 28,750 | 31,887 |
| Industrial | 24,787 | 23,290 | 30,949 |
| Corporate | 77 | 44 | 161 |
| Total capital expenditures | $144,731 | $151,995 | $177,309 |
Sales, based on the customer’s location, and property, plant and equipment by geographic area are as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Net sales: | |||
| United States | $2,432,811 | $2,319,352 | $2,153,121 |
| Germany | 247,354 | 164,794 | 203,661 |
| Other | 1,180,459 | 1,124,814 | 959,408 |
| Net sales | $3,860,624 | $3,608,960 | $3,316,190 |
| Property, plant and equipment, net: | |||
| United States | $704,707 | $636,828 | $546,335 |
| United Kingdom | 138,168 | 128,363 | 126,059 |
| Other | 177,031 | 163,397 | 153,866 |
| Property, plant and equipment, net | $1,019,906 | $928,588 | $826,260 |
Note 23 -Commitments and Contingencies
From time to time, we are involved in legal proceedings. We are not a party to any pending legal proceedings which management believes will result in a material adverse effect on our financial condition, results of operations or cash flows.
We are engaged in administrative proceedings with governmental agencies and legal proceedings with governmental agencies and other third parties in the normal course of our business, including litigation under Superfund laws, regarding environmental matters. We believe that adequate reserves have been established for our share of the estimated cost for all currently pending environmental administrative or legal proceedings and do not expect that these environmental matters will have a material adverse effect on our financial condition, results of operations or cash flows.
In the ordinary course of business we could be subject to ongoing claims or disputes from our customers, the ultimate settlement of which could have a material adverse impact on our consolidated results of operations. While the receivables and any loss provisions recorded to date reflect management's best estimate of the projected costs to complete a given project, there is still significant effort required to complete the ultimate deliverable. Future variability in internal cost and future profitability is dependent upon a number of factors including deliveries, performance and government budgetary pressures. The inability to achieve a satisfactory contractual solution, further unplanned delays, additional developmental cost growth or variations in any of the estimates used in the existing contract analysis could lead to further loss provisions. Additional losses could have a material adverse impact on our financial condition, results of operations or cash flows in the period in which the loss may be recognized. In the fourth quarter of 2025 we incurred $10,455 of charges related to a dispute with a customer, which are unique and outside the ordinary course of business. The charges consist of settlement costs and legal services.
We are contingently liable for $15,055 related to standby letters of credit issued by banks to third parties on our behalf at September 27, 2025. Purchase commitments outstanding at September 27, 2025 are $1,250,355 including $78,207 for property, plant and equipment.
Note 24 -Subsequent Events
On November 20, 2025, the Board of Directors declared a $0.29 per share quarterly dividend payable on issued and outstanding shares of our Class A and Class B common stock on December 17, 2025 to shareholders of record at the close of business on December 8, 2025.
Note 25 - Revision of Previously Issued Consolidated Financial Statements
As discussed in Note 1, we identified misstatements in our consolidated financial statements for 2023, 2024 and 2025. As a result, we revised our annual consolidated financial statements for 2023 and 2024 and our quarterly consolidated condensed financial statements for 2024 and 2025. Basic and diluted net earnings per share may not sum across due to rounding. A summary of the corrections are as follows:
| Consolidated Statement of Earnings | |||
|---|---|---|---|
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised |
| Net sales | $3,319,122 | $(2,932) | $3,316,190 |
| Cost of sales | 2,423,245 | (9,155) | 2,414,090 |
| Inventory write-down | 4,345 | — | 4,345 |
| Gross profit | 891,532 | 6,223 | 897,755 |
| Research and development | 106,551 | — | 106,551 |
| Selling, general and administrative | 469,836 | 5,101 | 474,937 |
| Interest | 63,578 | (3,740) | 59,838 |
| Asset impairment and fair value adjustment | 14,628 | — | 14,628 |
| Restructuring | 7,997 | — | 7,997 |
| Loss on sale of businesses | 900 | — | 900 |
| Gain on sale of buildings | (10,030) | — | (10,030) |
| Pension settlement | 12,542 | — | 12,542 |
| Other | 9,478 | (606) | 8,872 |
| Earnings before income taxes | 216,052 | 5,468 | 221,520 |
| Income taxes | 45,054 | 1,310 | 46,364 |
| Net earnings | $170,998 | $4,158 | $175,156 |
| Net earnings per share | |||
| Basic | $5.37 | $0.13 | $5.50 |
| Diluted | $5.34 | $0.13 | $5.47 |
| Consolidated Statement of Comprehensive Income | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| Net earnings | $170,998 | $4,158 | $175,156 |
| Other comprehensive income (loss) ("OCI"), net of tax: | |||
| Foreign currency translation adjustment | 41,538 | 9 | 41,547 |
| Retirement liability adjustment | 11,626 | — | 11,626 |
| Change in accumulated gain (loss) on derivatives | 3,269 | — | 3,269 |
| Other comprehensive income (loss), net of tax | 56,433 | 9 | 56,442 |
| Comprehensive income | $227,431 | $4,167 | $231,598 |
| Consolidated Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $68,959 | $— | $68,959 |
| Restricted cash | 185 | — | 185 |
| Receivables, net | 434,723 | 12,700 | 447,423 |
| Unbilled receivables | 706,601 | (71,814) | 634,787 |
| Inventories, net | 724,002 | (5,513) | 718,489 |
| Prepaid expenses and other current assets | 50,862 | 13,400 | 64,262 |
| Total current assets | 1,985,332 | (51,227) | 1,934,105 |
| Property, plant and equipment, net | 814,696 | 11,564 | 826,260 |
| Operating lease right-of-use assets | 56,067 | — | 56,067 |
| Goodwill | 821,301 | — | 821,301 |
| Intangible assets, net | 71,637 | — | 71,637 |
| Deferred income taxes | 8,749 | (26) | 8,723 |
| Other assets | 50,254 | — | 50,254 |
| Total assets | $3,808,036 | $(39,689) | $3,768,347 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $264,573 | $900 | $265,473 |
| Accrued compensation | 111,154 | 1,500 | 112,654 |
| Contract advances and progress billings | 377,977 | (40,270) | 337,707 |
| Accrued liabilities and other | 211,769 | 30,044 | 241,813 |
| Total current liabilities | 965,473 | (7,826) | 957,647 |
| Long-term debt, excluding current installments | 863,092 | — | 863,092 |
| Long-term pension and retirement obligations | 157,455 | — | 157,455 |
| Deferred income taxes | 37,626 | (4,151) | 33,475 |
| Other long-term liabilities | 148,303 | 6,618 | 154,921 |
| Total liabilities | 2,171,949 | (5,359) | 2,166,590 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,822 | — | 43,822 |
| Common stock - Class B | 7,458 | — | 7,458 |
| Additional paid-in capital | 608,270 | — | 608,270 |
| Retained earnings | 2,496,979 | (34,339) | 2,462,640 |
| Treasury shares | (1,057,938) | — | (1,057,938) |
| Stock Employee Compensation Trust | (114,769) | — | (114,769) |
| Supplemental Retirement Plan Trust | (93,126) | — | (93,126) |
| Accumulated other comprehensive loss | (254,609) | 9 | (254,600) |
| Total shareholders’ equity | 1,636,087 | (34,330) | 1,601,757 |
| Total liabilities and shareholders’ equity | $3,808,036 | $(39,689) | $3,768,347 |
| Consolidated Statement of Shareholders' Equity | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| COMMON STOCK | |||
| Beginning and end of year | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | |||
| Beginning of year | 516,123 | — | 516,123 |
| Issuance of treasury shares | 7,852 | — | 7,852 |
| Equity-based compensation expense | 8,119 | — | 8,119 |
| Adjustment to market - SECT and SERP | 76,176 | — | 76,176 |
| End of year | 608,270 | — | 608,270 |
| RETAINED EARNINGS | |||
| Beginning of year | 2,360,055 | (38,497) | 2,321,558 |
| Net earnings | 170,998 | 4,158 | 175,156 |
| Dividends | (34,074) | — | (34,074) |
| End of year | 2,496,979 | (34,339) | 2,462,640 |
| TREASURY SHARES AT COST | |||
| Beginning of year | (1,047,012) | — | (1,047,012) |
| Class A and B shares issued related to compensation | 16,107 | — | 16,107 |
| Class A and B shares purchased | (27,033) | — | (27,033) |
| End of year | (1,057,938) | — | (1,057,938) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | |||
| Beginning of year | (73,602) | — | (73,602) |
| Issuance of shares | 15,713 | — | 15,713 |
| Purchase of shares | (14,841) | — | (14,841) |
| Adjustment to market | (42,039) | — | (42,039) |
| End of year | (114,769) | — | (114,769) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | |||
| Beginning of year | (58,989) | — | (58,989) |
| Adjustment to market | (34,137) | — | (34,137) |
| End of year | (93,126) | — | (93,126) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | |||
| Beginning of year | (311,042) | — | (311,042) |
| Other comprehensive income (loss) | 56,433 | 9 | 56,442 |
| End of year | (254,609) | 9 | (254,600) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,636,087 | $(34,330) | $1,601,757 |
| Consolidated Statement of Cash Flows | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $170,998 | $4,158 | $175,156 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 78,692 | (929) | 77,763 |
| Amortization | 11,541 | — | 11,541 |
| Deferred income taxes | (35,531) | 534 | (34,997) |
| Equity-based compensation expense | 10,582 | — | 10,582 |
| Loss on sale of businesses | 900 | — | 900 |
| Asset impairment and inventory write-down | 18,973 | — | 18,973 |
| Gain on sale of buildings | (10,030) | — | (10,030) |
| Pension settlement | 12,542 | — | 12,542 |
| Other | 6,244 | — | 6,244 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | (56,575) | (12,700) | (69,275) |
| Unbilled receivables | (87,915) | 52,492 | (35,423) |
| Inventories | (130,378) | 2,936 | (127,442) |
| Accounts payable | 28,641 | — | 28,641 |
| Contract advances and progress billings | 79,983 | (40,535) | 39,448 |
| Accrued expenses | (1,692) | (1,493) | (3,185) |
| Accrued income taxes | 22,869 | 775 | 23,644 |
| Net pension and post retirement liabilities | 13,940 | — | 13,940 |
| Other assets and liabilities | 2,151 | (1,522) | 629 |
| Net cash provided (used) by operating activities | 135,935 | 3,716 | 139,651 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Purchase of property, plant and equipment | (173,286) | (4,023) | (177,309) |
| Net proceeds from businesses sold | 1,892 | — | 1,892 |
| Net proceeds from buildings sold | 19,702 | — | 19,702 |
| Other investing transactions | (11,455) | — | (11,455) |
| Net cash provided (used) by investing activities | (163,147) | (4,023) | (167,170) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 1,044,101 | — | 1,044,101 |
| Payments on revolving lines of credit | (1,017,420) | — | (1,017,420) |
| Payments on long-term debt | (916) | — | (916) |
| Payments on finance lease obligations | (4,620) | 307 | (4,313) |
| Payment of dividends | (34,074) | — | (34,074) |
| Proceeds from sale of treasury stock | 19,785 | — | 19,785 |
| Purchase of outstanding shares for treasury | (29,306) | — | (29,306) |
| Proceeds from sale of stock held by SECT | 15,713 | — | 15,713 |
| Purchase of stock held by SECT | (14,251) | — | (14,251) |
| Other financing transactions | (2,027) | — | (2,027) |
| Net cash provided (used) by financing activities | (23,015) | 307 | (22,708) |
| Effect of exchange rate changes on cash | 2,043 | — | 2,043 |
| Increase (decrease) in cash, cash equivalents and restricted cash | (48,184) | — | (48,184) |
| Cash, cash equivalents and restricted cash at beginning of year | 117,328 | — | 117,328 |
| Cash, cash equivalents and restricted cash at end of year | $69,144 | $— | $69,144 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Interest paid | $63,193 | $(3,740) | $59,453 |
| Income taxes paid, net of refunds | 69,253 | — | 69,253 |
| Treasury shares issued as compensation | 4,174 | — | 4,174 |
| Assets acquired through lease financing | 61,805 | 2,229 | 64,034 |
| Consolidated Condensed Statement of Earnings | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised |
| Net sales | $856,850 | $(1,628) | $855,222 |
| Cost of sales | 623,651 | (9,859) | 613,792 |
| Inventory write-down | — | — | — |
| Gross profit | 233,199 | 8,231 | 241,430 |
| Research and development | 30,579 | — | 30,579 |
| Selling, general and administrative | 118,725 | 2,033 | 120,758 |
| Interest | 16,694 | (1,547) | 15,147 |
| Restructuring | 1,889 | — | 1,889 |
| Other | 2,701 | 1,456 | 4,157 |
| Earnings before income taxes | 62,611 | 6,289 | 68,900 |
| Income taxes | 14,799 | 1,466 | 16,265 |
| Net earnings | $47,812 | $4,823 | $52,635 |
| Net earnings per share | |||
| Basic | $1.50 | $0.15 | $1.65 |
| Diluted | $1.48 | $0.15 | $1.63 |
| Consolidated Condensed Statement of Comprehensive Income | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| Net earnings | $47,812 | $4,823 | $52,635 |
| Other comprehensive income (loss) ("OCI"), net of tax: | |||
| Foreign currency translation adjustment | 31,013 | 31 | 31,044 |
| Retirement liability adjustment | 1,678 | — | 1,678 |
| Change in accumulated gain (loss) on derivatives | 318 | — | 318 |
| Other comprehensive income (loss), net of tax | 33,009 | 31 | 33,040 |
| Comprehensive income | $80,821 | $4,854 | $85,675 |
| Consolidated Condensed Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $126,398 | $— | $126,398 |
| Restricted cash | 430 | — | 430 |
| Receivables, net | 381,609 | — | 381,609 |
| Unbilled receivables | 760,561 | (17,064) | 743,497 |
| Inventories, net | 788,040 | (4,372) | 783,668 |
| Prepaid expenses and other current assets | 59,577 | — | 59,577 |
| Total current assets | 2,116,615 | (21,436) | 2,095,179 |
| Property, plant and equipment, net | 842,682 | 13,780 | 856,462 |
| Operating lease right-of-use assets | 59,489 | — | 59,489 |
| Goodwill | 833,413 | — | 833,413 |
| Intangible assets, net | 72,663 | — | 72,663 |
| Deferred income taxes | 9,284 | (34) | 9,250 |
| Other assets | 53,809 | — | 53,809 |
| Total assets | $3,987,955 | $(7,690) | $3,980,265 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $261,155 | $900 | $262,055 |
| Accrued compensation | 64,099 | 1,850 | 65,949 |
| Contract advances and progress billings | 445,706 | 841 | 446,547 |
| Accrued liabilities and other | 238,871 | 14,272 | 253,143 |
| Total current liabilities | 1,009,831 | 17,863 | 1,027,694 |
| Long-term debt, excluding current installments | 920,103 | — | 920,103 |
| Long-term pension and retirement obligations | 160,825 | — | 160,825 |
| Deferred income taxes | 35,214 | (3,128) | 32,086 |
| Other long-term liabilities | 154,765 | 7,051 | 161,816 |
| Total liabilities | 2,280,738 | 21,786 | 2,302,524 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,826 | — | 43,826 |
| Common stock - Class B | 7,454 | — | 7,454 |
| Additional paid-in capital | 673,261 | — | 673,261 |
| Retained earnings | 2,536,172 | (29,516) | 2,506,656 |
| Treasury shares | (1,065,654) | — | (1,065,654) |
| Stock Employee Compensation Trust | (146,373) | — | (146,373) |
| Supplemental Retirement Plan Trust | (119,869) | — | (119,869) |
| Accumulated other comprehensive loss | (221,600) | 40 | (221,560) |
| Total shareholders’ equity | 1,707,217 | (29,476) | 1,677,741 |
| Total liabilities and shareholders’ equity | $3,987,955 | $(7,690) | $3,980,265 |
| Consolidated Condensed Statement of Shareholders' Equity | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| COMMON STOCK | |||
| Beginning and end of year | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | |||
| Beginning of year | 608,270 | — | 608,270 |
| Issuance of treasury shares | 2,160 | — | 2,160 |
| Equity-based compensation expense | 3,454 | — | 3,454 |
| Adjustment to market - SECT and SERP | 59,377 | — | 59,377 |
| End of year | 673,261 | — | 673,261 |
| RETAINED EARNINGS | |||
| Beginning of year | 2,496,979 | (34,339) | 2,462,640 |
| Net earnings | 47,812 | 4,823 | 52,635 |
| Dividends | (8,619) | — | (8,619) |
| End of year | 2,536,172 | (29,516) | 2,506,656 |
| TREASURY SHARES AT COST | |||
| Beginning of year | (1,057,938) | — | (1,057,938) |
| Class A and B shares issued related to compensation | 995 | — | 995 |
| Class A and B shares purchased | (8,711) | — | (8,711) |
| End of year | (1,065,654) | — | (1,065,654) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | |||
| Beginning of year | (114,769) | — | (114,769) |
| Issuance of shares | 5,001 | — | 5,001 |
| Purchase of shares | (3,971) | — | (3,971) |
| Adjustment to market | (32,634) | — | (32,634) |
| End of year | (146,373) | — | (146,373) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | |||
| Beginning of year | (93,126) | — | (93,126) |
| Adjustment to market | (26,743) | — | (26,743) |
| End of year | (119,869) | — | (119,869) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | |||
| Beginning of year | (254,609) | 9 | (254,600) |
| Other comprehensive income (loss) | 33,009 | 31 | 33,040 |
| End of year | (221,600) | 40 | (221,560) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,707,217 | $(29,476) | $1,677,741 |
| Consolidated Condensed Statement of Cash Flows | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $47,812 | $4,823 | $52,635 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 20,927 | (232) | 20,695 |
| Amortization | 2,720 | — | 2,720 |
| Deferred income taxes | (4,547) | 1,028 | (3,519) |
| Equity-based compensation expense | 4,165 | — | 4,165 |
| Other | (2,478) | — | (2,478) |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | 58,887 | 12,700 | 71,587 |
| Unbilled receivables | (51,015) | (54,708) | (105,723) |
| Inventories | (46,852) | (1,141) | (47,993) |
| Accounts payable | (5,752) | — | (5,752) |
| Contract advances and progress billings | 64,171 | 41,063 | 105,234 |
| Accrued expenses | (31,814) | (15,848) | (47,662) |
| Accrued income taxes | 12,324 | 436 | 12,760 |
| Net pension and post retirement liabilities | 2,957 | — | 2,957 |
| Other assets and liabilities | (11,114) | 13,410 | 2,296 |
| Net cash provided (used) by operating activities | 60,391 | 1,531 | 61,922 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Acquisitions of businesses, net of cash acquired | (5,212) | — | (5,212) |
| Purchase of property, plant and equipment | (37,416) | (1,634) | (39,050) |
| Other investing transactions | (479) | — | (479) |
| Net cash provided (used) by investing activities | (43,107) | (1,634) | (44,741) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 279,500 | — | 279,500 |
| Payments on revolving lines of credit | (223,000) | — | (223,000) |
| Payments on finance lease obligations | (1,286) | 103 | (1,183) |
| Payment of dividends | (8,619) | — | (8,619) |
| Proceeds from sale of treasury stock | 581 | — | 581 |
| Purchase of outstanding shares for treasury | (8,711) | — | (8,711) |
| Proceeds from sale of stock held by SECT | 5,001 | — | 5,001 |
| Purchase of stock held by SECT | (4,561) | — | (4,561) |
| Net cash provided (used) by financing activities | 38,905 | 103 | 39,008 |
| Effect of exchange rate changes on cash | 1,495 | — | 1,495 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 57,684 | — | 57,684 |
| Cash, cash equivalents and restricted cash at beginning of year | 69,144 | — | 69,144 |
| Cash, cash equivalents and restricted cash at end of year | $126,828 | $— | $126,828 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Treasury shares issued as compensation | $2,574 | $— | $2,574 |
| Assets acquired through lease financing | 7,845 | 288 | 8,133 |
| Consolidated Condensed Statement of Earnings | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Six Months Ended | ||||||
| March 30, 2024 | March 30, 2024 | |||||
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net sales | $930,303 | $(10,095) | $920,208 | $1,787,153 | $(11,723) | $1,775,430 |
| Cost of sales | 663,350 | (2,151) | 661,199 | 1,287,001 | (12,010) | 1,274,991 |
| Inventory write-down | 175 | — | 175 | 175 | — | 175 |
| Gross profit | 266,778 | (7,944) | 258,834 | 499,977 | 287 | 500,264 |
| Research and development | 28,382 | — | 28,382 | 58,961 | — | 58,961 |
| Selling, general and administrative | 124,961 | 967 | 125,928 | 243,686 | 3,000 | 246,686 |
| Interest | 18,003 | (1,246) | 16,757 | 34,697 | (2,793) | 31,904 |
| Asset impairment and fair value adjustment | 6,750 | — | 6,750 | 6,750 | — | 6,750 |
| Restructuring | 6,750 | — | 6,750 | 8,639 | — | 8,639 |
| Other | 3,183 | (483) | 2,700 | 5,884 | 973 | 6,857 |
| Earnings before income taxes | 78,749 | (7,182) | 71,567 | 141,360 | (893) | 140,467 |
| Income taxes | 18,746 | (1,685) | 17,061 | 33,545 | (219) | 33,326 |
| Net earnings | $60,003 | $(5,497) | $54,506 | $107,815 | $(674) | $107,141 |
| Net earnings per share | ||||||
| Basic | $1.88 | $(0.17) | $1.71 | $3.38 | $(0.02) | $3.35 |
| Diluted | $1.86 | $(0.17) | $1.69 | $3.34 | $(0.02) | $3.32 |
| Consolidated Condensed Statement of Comprehensive Income | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Six Months Ended | ||||||
| March 30, 2024 | March 30, 2024 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net earnings | $60,003 | $(5,497) | $54,506 | $107,815 | $(674) | $107,141 |
| Other comprehensive income (loss) ("OCI"), net of tax: | ||||||
| Foreign currency translation adjustment | (13,726) | (6) | (13,732) | 17,287 | 25 | 17,312 |
| Retirement liability adjustment | 2,173 | — | 2,173 | 3,851 | — | 3,851 |
| Change in accumulated gain (loss) on derivatives | 200 | — | 200 | 518 | — | 518 |
| Other comprehensive income (loss), net of tax | (11,353) | (6) | (11,359) | 21,656 | 25 | 21,681 |
| Comprehensive income | $48,650 | $(5,503) | $43,147 | $129,471 | $(649) | $128,822 |
| Consolidated Condensed Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $59,066 | $— | $59,066 |
| Restricted cash | 665 | — | 665 |
| Receivables, net | 419,399 | — | 419,399 |
| Unbilled receivables | 794,167 | (20,788) | 773,379 |
| Inventories, net | 810,483 | (2,631) | 807,852 |
| Prepaid expenses and other current assets | 73,165 | 2,746 | 75,911 |
| Total current assets | 2,156,945 | (20,673) | 2,136,272 |
| Property, plant and equipment, net | 869,303 | 16,742 | 886,045 |
| Operating lease right-of-use assets | 57,074 | — | 57,074 |
| Goodwill | 828,469 | — | 828,469 |
| Intangible assets, net | 68,876 | — | 68,876 |
| Deferred income taxes | 9,063 | 6,493 | 15,556 |
| Other assets | 49,390 | — | 49,390 |
| Total assets | $4,039,120 | $2,562 | $4,041,682 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $267,731 | $900 | $268,631 |
| Accrued compensation | 73,961 | 2,200 | 76,161 |
| Contract advances and progress billings | 404,876 | 354 | 405,230 |
| Accrued liabilities and other | 257,960 | 23,781 | 281,741 |
| Total current liabilities | 1,004,528 | 27,235 | 1,031,763 |
| Long-term debt, excluding current installments | 948,615 | — | 948,615 |
| Long-term pension and retirement obligations | 160,265 | — | 160,265 |
| Deferred income taxes | 22,765 | 1,781 | 24,546 |
| Other long-term liabilities | 149,688 | 8,525 | 158,213 |
| Total liabilities | 2,285,861 | 37,541 | 2,323,402 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,826 | — | 43,826 |
| Common stock - Class B | 7,454 | — | 7,454 |
| Additional paid-in capital | 702,272 | — | 702,272 |
| Retained earnings | 2,587,222 | (35,013) | 2,552,209 |
| Treasury shares | (1,071,558) | — | (1,071,558) |
| Stock Employee Compensation Trust | (153,295) | — | (153,295) |
| Supplemental Retirement Plan Trust | (129,709) | — | (129,709) |
| Accumulated other comprehensive loss | (232,953) | 34 | (232,919) |
| Total shareholders’ equity | 1,753,259 | (34,979) | 1,718,280 |
| Total liabilities and shareholders’ equity | $4,039,120 | $2,562 | $4,041,682 |
| Consolidated Condensed Statement of Shareholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Six Months Ended | ||||||
| March 30, 2024 | March 30, 2024 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| COMMON STOCK | ||||||
| Beginning and end of year | $51,280 | $— | $51,280 | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | ||||||
| Beginning of year | 673,261 | — | 673,261 | 608,270 | — | 608,270 |
| Issuance of treasury shares | 4,126 | — | 4,126 | 6,286 | — | 6,286 |
| Equity-based compensation expense | 2,182 | — | 2,182 | 5,636 | — | 5,636 |
| Adjustment to market - SECT and SERP | 22,703 | — | 22,703 | 82,080 | — | 82,080 |
| End of year | 702,272 | — | 702,272 | 702,272 | — | 702,272 |
| RETAINED EARNINGS | ||||||
| Beginning of year | 2,536,172 | (29,516) | 2,506,656 | 2,496,979 | (34,339) | 2,462,640 |
| Net earnings | 60,003 | (5,497) | 54,506 | 107,815 | (674) | 107,141 |
| Dividends | (8,953) | — | (8,953) | (17,572) | — | (17,572) |
| End of year | 2,587,222 | (35,013) | 2,552,209 | 2,587,222 | (35,013) | 2,552,209 |
| TREASURY SHARES AT COST | ||||||
| Beginning of year | (1,065,654) | — | (1,065,654) | (1,057,938) | — | (1,057,938) |
| Class A and B shares issued related to compensation | 5,623 | — | 5,623 | 6,618 | — | 6,618 |
| Class A and B shares purchased | (11,527) | — | (11,527) | (20,238) | — | (20,238) |
| End of year | (1,071,558) | — | (1,071,558) | (1,071,558) | — | (1,071,558) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | ||||||
| Beginning of year | (146,373) | — | (146,373) | (114,769) | — | (114,769) |
| Issuance of shares | 10,787 | — | 10,787 | 15,788 | — | 15,788 |
| Purchase of shares | (4,846) | — | (4,846) | (8,817) | — | (8,817) |
| Adjustment to market | (12,863) | — | (12,863) | (45,497) | — | (45,497) |
| End of year | (153,295) | — | (153,295) | (153,295) | — | (153,295) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | ||||||
| Beginning of year | (119,869) | — | (119,869) | (93,126) | — | (93,126) |
| Adjustment to market | (9,840) | — | (9,840) | (36,583) | — | (36,583) |
| End of year | (129,709) | — | (129,709) | (129,709) | — | (129,709) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | ||||||
| Beginning of year | (221,600) | 40 | (221,560) | (254,609) | 9 | (254,600) |
| Other comprehensive income (loss) | (11,353) | (6) | (11,359) | 21,656 | 25 | 21,681 |
| End of year | (232,953) | 34 | (232,919) | (232,953) | 34 | (232,919) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,753,259 | $(34,979) | $1,718,280 | $1,753,259 | $(34,979) | $1,718,280 |
| Consolidated Statement of Cash Flows | |||
|---|---|---|---|
| Six Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $107,815 | $(674) | $107,141 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 42,276 | (574) | 41,702 |
| Amortization | 5,296 | — | 5,296 |
| Deferred income taxes | (17,805) | (588) | (18,393) |
| Equity-based compensation expense | 7,212 | — | 7,212 |
| Asset impairment and inventory write-down | 6,925 | — | 6,925 |
| Other | 2,207 | — | 2,207 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | 17,469 | 12,700 | 30,169 |
| Unbilled receivables | (86,197) | (50,984) | (137,181) |
| Inventories | (77,396) | (2,882) | (80,278) |
| Accounts payable | 1,847 | — | 1,847 |
| Contract advances and progress billings | 24,512 | 40,579 | 65,091 |
| Accrued expenses | 903 | (8,575) | (7,672) |
| Accrued income taxes | 10,833 | 369 | 11,202 |
| Net pension and post retirement liabilities | 5,687 | — | 5,687 |
| Other assets and liabilities | (35,195) | 13,376 | (21,819) |
| Net cash provided (used) by operating activities | 16,389 | 2,747 | 19,136 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Acquisitions of businesses, net of cash acquired | (5,911) | — | (5,911) |
| Purchase of property, plant and equipment | (77,530) | (2,980) | (80,510) |
| Other investing transactions | (515) | — | (515) |
| Net cash provided (used) by investing activities | (83,956) | (2,980) | (86,936) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 509,500 | — | 509,500 |
| Payments on revolving lines of credit | (425,000) | — | (425,000) |
| Payments on finance lease obligations | (2,741) | 233 | (2,508) |
| Payment of dividends | (17,572) | — | (17,572) |
| Proceeds from sale of treasury stock | 7,579 | — | 7,579 |
| Purchase of outstanding shares for treasury | (20,238) | — | (20,238) |
| Proceeds from sale of stock held by SECT | 15,788 | — | 15,788 |
| Purchase of stock held by SECT | (9,407) | — | (9,407) |
| Net cash provided (used) by financing activities | 57,909 | 233 | 58,142 |
| Effect of exchange rate changes on cash | 245 | — | 245 |
| Increase (decrease) in cash, cash equivalents and restricted cash | (9,413) | — | (9,413) |
| Cash, cash equivalents and restricted cash at beginning of year | 69,144 | — | 69,144 |
| Cash, cash equivalents and restricted cash at end of year | $59,731 | $— | $59,731 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Treasury shares issued as compensation | $5,325 | $— | $5,325 |
| Assets acquired through lease financing | 18,160 | 1,556 | 19,716 |
| Consolidated Condensed Statement of Earnings | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Nine Months Ended | ||||||
| June 29, 2024 | June 29, 2024 | |||||
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net sales | $904,735 | $9,400 | $914,135 | $2,691,888 | $(2,323) | $2,689,565 |
| Cost of sales | 651,672 | 5,202 | 656,874 | 1,938,673 | (6,808) | 1,931,865 |
| Inventory write-down | 1,600 | — | 1,600 | 1,775 | — | 1,775 |
| Gross profit | 251,463 | 4,198 | 255,661 | 751,440 | 4,485 | 755,925 |
| Research and development | 27,791 | — | 27,791 | 86,752 | — | 86,752 |
| Selling, general and administrative | 126,361 | 1,829 | 128,190 | 370,047 | 4,829 | 374,876 |
| Interest | 18,153 | (1,124) | 17,029 | 52,850 | (3,917) | 48,933 |
| Asset impairment and fair value adjustment | 112 | — | 112 | 6,862 | — | 6,862 |
| Restructuring | 3,984 | — | 3,984 | 12,623 | — | 12,623 |
| Other | 4,157 | (115) | 4,042 | 10,041 | 858 | 10,899 |
| Earnings before income taxes | 70,905 | 3,608 | 74,513 | 212,265 | 2,715 | 214,980 |
| Income taxes | 14,545 | 857 | 15,402 | 48,090 | 638 | 48,728 |
| Net earnings | $56,360 | $2,751 | $59,111 | $164,175 | $2,077 | $166,252 |
| Net earnings per share | ||||||
| Basic | $1.76 | $0.09 | $1.85 | $5.14 | $0.07 | $5.20 |
| Diluted | $1.74 | $0.08 | $1.82 | $5.08 | $0.06 | $5.14 |
| Consolidated Condensed Statement of Comprehensive Income | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Nine Months Ended | ||||||
| June 29, 2024 | June 29, 2024 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net earnings | $56,360 | $2,751 | $59,111 | $164,175 | $2,077 | $166,252 |
| Other comprehensive income (loss) ("OCI"), net of tax: | ||||||
| Foreign currency translation adjustment | (6,650) | (5) | (6,655) | 10,637 | 20 | 10,657 |
| Retirement liability adjustment | 2,059 | — | 2,059 | 5,910 | — | 5,910 |
| Change in accumulated gain (loss) on derivatives | — | — | — | 518 | — | 518 |
| Other comprehensive income (loss), net of tax | (4,591) | (5) | (4,596) | 17,065 | 20 | 17,085 |
| Comprehensive income | $51,769 | $2,746 | $54,515 | $181,240 | $2,097 | $183,337 |
| Consolidated Condensed Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $50,572 | $— | $50,572 |
| Restricted cash | 946 | — | 946 |
| Receivables, net | 452,967 | — | 452,967 |
| Unbilled receivables | 766,445 | (20,765) | 745,680 |
| Inventories, net | 831,377 | (2,859) | 828,518 |
| Prepaid expenses and other current assets | 70,081 | 2,515 | 72,596 |
| Total current assets | 2,172,388 | (21,109) | 2,151,279 |
| Property, plant and equipment, net | 886,013 | 18,697 | 904,710 |
| Operating lease right-of-use assets | 57,669 | — | 57,669 |
| Goodwill | 827,319 | — | 827,319 |
| Intangible assets, net | 66,422 | — | 66,422 |
| Deferred income taxes | 9,050 | 15,051 | 24,101 |
| Other assets | 48,887 | — | 48,887 |
| Total assets | $4,067,748 | $12,639 | $4,080,387 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $266,294 | $900 | $267,194 |
| Accrued compensation | 98,981 | 2,550 | 101,531 |
| Contract advances and progress billings | 353,496 | 240 | 353,736 |
| Accrued liabilities and other | 269,633 | 21,191 | 290,824 |
| Total current liabilities | 988,404 | 24,881 | 1,013,285 |
| Long-term debt, excluding current installments | 958,127 | — | 958,127 |
| Long-term pension and retirement obligations | 160,635 | — | 160,635 |
| Deferred income taxes | 13,668 | 10,951 | 24,619 |
| Other long-term liabilities | 153,122 | 9,040 | 162,162 |
| Total liabilities | 2,273,956 | 44,872 | 2,318,828 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,835 | — | 43,835 |
| Common stock - Class B | 7,445 | — | 7,445 |
| Additional paid-in capital | 726,656 | — | 726,656 |
| Retained earnings | 2,634,633 | (32,262) | 2,602,371 |
| Treasury shares | (1,073,027) | — | (1,073,027) |
| Stock Employee Compensation Trust | (167,757) | — | (167,757) |
| Supplemental Retirement Plan Trust | (140,449) | — | (140,449) |
| Accumulated other comprehensive loss | (237,544) | 29 | (237,515) |
| Total shareholders’ equity | 1,793,792 | (32,233) | 1,761,559 |
| Total liabilities and shareholders’ equity | $4,067,748 | $12,639 | $4,080,387 |
| Consolidated Condensed Statement of Shareholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Nine Months Ended | ||||||
| June 29, 2024 | June 29, 2024 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| COMMON STOCK | ||||||
| Beginning and end of year | $51,280 | $— | $51,280 | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | ||||||
| Beginning of year | 702,272 | — | 702,272 | 608,270 | — | 608,270 |
| Issuance of treasury shares | (127) | — | (127) | 6,159 | — | 6,159 |
| Equity-based compensation expense | 3,316 | — | 3,316 | 8,952 | — | 8,952 |
| Adjustment to market - SECT and SERP | 21,195 | — | 21,195 | 103,275 | — | 103,275 |
| End of year | 726,656 | — | 726,656 | 726,656 | — | 726,656 |
| RETAINED EARNINGS | ||||||
| Beginning of year | 2,587,222 | (35,013) | 2,552,209 | 2,496,979 | (34,339) | 2,462,640 |
| Net earnings | 56,360 | 2,751 | 59,111 | 164,175 | 2,077 | 166,252 |
| Dividends | (8,949) | — | (8,949) | (26,521) | — | (26,521) |
| End of year | 2,634,633 | (32,262) | 2,602,371 | 2,634,633 | (32,262) | 2,602,371 |
| TREASURY SHARES AT COST | ||||||
| Beginning of year | (1,071,558) | — | (1,071,558) | (1,057,938) | — | (1,057,938) |
| Class A and B shares issued related to compensation | 125 | — | 125 | 6,743 | — | 6,743 |
| Class A and B shares purchased | (1,594) | — | (1,594) | (21,832) | — | (21,832) |
| End of year | (1,073,027) | — | (1,073,027) | (1,073,027) | — | (1,073,027) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | ||||||
| Beginning of year | (153,295) | — | (153,295) | (114,769) | — | (114,769) |
| Issuance of shares | 882 | — | 882 | 16,670 | — | 16,670 |
| Purchase of shares | (4,889) | — | (4,889) | (13,706) | — | (13,706) |
| Adjustment to market | (10,455) | — | (10,455) | (55,952) | — | (55,952) |
| End of year | (167,757) | — | (167,757) | (167,757) | — | (167,757) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | ||||||
| Beginning of year | (129,709) | — | (129,709) | (93,126) | — | (93,126) |
| Adjustment to market | (10,740) | — | (10,740) | (47,323) | — | (47,323) |
| End of year | (140,449) | — | (140,449) | (140,449) | — | (140,449) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | ||||||
| Beginning of year | (232,953) | 34 | (232,919) | (254,609) | 9 | (254,600) |
| Other comprehensive income (loss) | (4,591) | (5) | (4,596) | 17,065 | 20 | 17,085 |
| End of year | (237,544) | 29 | (237,515) | (237,544) | 29 | (237,515) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,793,792 | $(32,233) | $1,761,559 | $1,793,792 | $(32,233) | $1,761,559 |
| Consolidated Condensed Statement of Cash Flows | |||
|---|---|---|---|
| Nine Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $164,175 | $2,077 | $166,252 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 64,302 | (968) | 63,334 |
| Amortization | 7,677 | — | 7,677 |
| Deferred income taxes | (26,483) | 25 | (26,458) |
| Equity-based compensation expense | 11,301 | — | 11,301 |
| Asset impairment and inventory write-down | 8,637 | — | 8,637 |
| Other | 5,374 | — | 5,374 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | (18,677) | 12,700 | (5,977) |
| Unbilled receivables | (57,723) | (51,008) | (108,731) |
| Inventories | (105,629) | (2,654) | (108,283) |
| Accounts payable | 918 | — | 918 |
| Contract advances and progress billings | (26,882) | 40,464 | 13,582 |
| Accrued expenses | 36,928 | (10,756) | 26,172 |
| Accrued income taxes | 9,832 | 612 | 10,444 |
| Net pension and post retirement liabilities | 8,783 | — | 8,783 |
| Other assets and liabilities | (35,978) | 13,353 | (22,625) |
| Net cash provided (used) by operating activities | 46,555 | 3,845 | 50,400 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Acquisitions of businesses, net of cash acquired | (5,911) | — | (5,911) |
| Purchase of property, plant and equipment | (109,616) | (4,207) | (113,823) |
| Net proceeds from businesses sold | 1,627 | — | 1,627 |
| Other investing transactions | (646) | — | (646) |
| Net cash provided (used) by investing activities | (114,546) | (4,207) | (118,753) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 784,500 | — | 784,500 |
| Payments on revolving lines of credit | (691,000) | — | (691,000) |
| Payments on finance lease obligations | (4,468) | 362 | (4,106) |
| Payment of dividends | (26,521) | — | (26,521) |
| Proceeds from sale of treasury stock | 7,579 | — | 7,579 |
| Purchase of outstanding shares for treasury | (21,832) | — | (21,832) |
| Proceeds from sale of stock held by SECT | 16,670 | — | 16,670 |
| Purchase of stock held by SECT | (14,296) | — | (14,296) |
| Net cash provided (used) by financing activities | 50,632 | 362 | 50,994 |
| Effect of exchange rate changes on cash | (267) | — | (267) |
| Increase (decrease) in cash, cash equivalents and restricted cash | (17,626) | — | (17,626) |
| Cash, cash equivalents and restricted cash at beginning of year | 69,144 | — | 69,144 |
| Cash, cash equivalents and restricted cash at end of year | $51,518 | $— | $51,518 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Treasury shares issued as compensation | $5,323 | $— | $5,323 |
| Assets acquired through lease financing | 27,034 | 1,876 | 28,910 |
| Consolidated Statement of Earnings | |||
|---|---|---|---|
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised |
| Net sales | $3,609,160 | $(200) | $3,608,960 |
| Cost of sales | 2,605,214 | (15,689) | 2,589,525 |
| Inventory write-down | 7,027 | — | 7,027 |
| Gross profit | 996,919 | 15,489 | 1,012,408 |
| Research and development | 112,773 | — | 112,773 |
| Selling, general and administrative | 494,887 | 6,366 | 501,253 |
| Interest | 62,112 | 4,218 | 66,330 |
| Asset impairment and fair value adjustment | 22,149 | — | 22,149 |
| Restructuring | 23,788 | — | 23,788 |
| Gain on sale of buildings | (979) | — | (979) |
| Other | 14,376 | 2,972 | 17,348 |
| Earnings before income taxes | 267,813 | 1,933 | 269,746 |
| Income taxes | 60,593 | 367 | 60,960 |
| Net earnings | $207,220 | $1,566 | $208,786 |
| Net earnings per share | |||
| Basic | $6.48 | $0.05 | $6.53 |
| Diluted | $6.40 | $0.05 | $6.45 |
| Consolidated Statement of Comprehensive Income | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| Net earnings | $207,220 | $1,566 | $208,786 |
| Other comprehensive income (loss) ("OCI"), net of tax: | |||
| Foreign currency translation adjustment | 44,948 | 7 | 44,955 |
| Retirement liability adjustment | 5,374 | 941 | 6,315 |
| Change in accumulated gain (loss) on derivatives | 518 | — | 518 |
| Other comprehensive income (loss), net of tax | 50,840 | 948 | 51,788 |
| Comprehensive income | $258,060 | $2,514 | $260,574 |
| Consolidated Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $61,694 | $— | $61,694 |
| Restricted cash | 123 | — | 123 |
| Receivables, net | 419,971 | — | 419,971 |
| Unbilled receivables | 709,014 | (18,442) | 690,572 |
| Inventories, net | 863,702 | (1,161) | 862,541 |
| Prepaid expenses and other current assets | 86,245 | 1,500 | 87,745 |
| Total current assets | 2,140,749 | (18,103) | 2,122,646 |
| Property, plant and equipment, net | 929,357 | (769) | 928,588 |
| Operating lease right-of-use assets | 52,591 | — | 52,591 |
| Goodwill | 833,764 | — | 833,764 |
| Intangible assets, net | 63,479 | — | 63,479 |
| Deferred income taxes | 20,991 | 2,893 | 23,884 |
| Other assets | 52,695 | — | 52,695 |
| Total assets | $4,093,626 | $(15,979) | $4,077,647 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $292,988 | $900 | $293,888 |
| Accrued compensation | 101,127 | 2,900 | 104,027 |
| Contract advances and progress billings | 299,732 | 2,394 | 302,126 |
| Accrued liabilities and other | 305,180 | 8,193 | 313,373 |
| Total current liabilities | 999,027 | 14,387 | 1,013,414 |
| Long-term debt, excluding current installments | 874,139 | — | 874,139 |
| Long-term pension and retirement obligations | 167,161 | — | 167,161 |
| Deferred income taxes | 27,738 | (86) | 27,652 |
| Other long-term liabilities | 164,928 | 1,536 | 166,464 |
| Total liabilities | 2,232,993 | 15,837 | 2,248,830 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,835 | — | 43,835 |
| Common stock - Class B | 7,445 | — | 7,445 |
| Additional paid-in capital | 784,509 | — | 784,509 |
| Retained earnings | 2,668,723 | (32,773) | 2,635,950 |
| Treasury shares | (1,082,240) | — | (1,082,240) |
| Stock Employee Compensation Trust | (194,049) | — | (194,049) |
| Supplemental Retirement Plan Trust | (163,821) | — | (163,821) |
| Accumulated other comprehensive loss | (203,769) | 957 | (202,812) |
| Total shareholders’ equity | 1,860,633 | (31,816) | 1,828,817 |
| Total liabilities and shareholders’ equity | $4,093,626 | $(15,979) | $4,077,647 |
| Consolidated Statement of Shareholders' Equity | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| COMMON STOCK | |||
| Beginning and end of year | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | |||
| Beginning of year | 608,270 | — | 608,270 |
| Issuance of treasury shares | 8,572 | — | 8,572 |
| Equity-based compensation expense | 11,737 | — | 11,737 |
| Adjustment to market - SECT and SERP | 155,930 | — | 155,930 |
| End of year | 784,509 | — | 784,509 |
| RETAINED EARNINGS | |||
| Beginning of year | 2,496,979 | (34,339) | 2,462,640 |
| Net earnings | 207,220 | 1,566 | 208,786 |
| Dividends | (35,476) | — | (35,476) |
| End of year | 2,668,723 | (32,773) | 2,635,950 |
| TREASURY SHARES AT COST | |||
| Beginning of year | (1,057,938) | — | (1,057,938) |
| Class A and B shares issued related to compensation | 12,436 | — | 12,436 |
| Class A and B shares purchased | (36,738) | — | (36,738) |
| End of year | (1,082,240) | — | (1,082,240) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | |||
| Beginning of year | (114,769) | — | (114,769) |
| Issuance of shares | 28,202 | — | 28,202 |
| Purchase of shares | (22,247) | — | (22,247) |
| Adjustment to market | (85,235) | — | (85,235) |
| End of year | (194,049) | — | (194,049) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | |||
| Beginning of year | (93,126) | — | (93,126) |
| Adjustment to market | (70,695) | — | (70,695) |
| End of year | (163,821) | — | (163,821) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | |||
| Beginning of year | (254,609) | 9 | (254,600) |
| Other comprehensive income (loss) | 50,840 | 948 | 51,788 |
| End of year | (203,769) | 957 | (202,812) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,860,633 | $(31,816) | $1,828,817 |
| Consolidated Statement of Cash Flows | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $207,220 | $1,566 | $208,786 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 82,957 | 2,921 | 85,878 |
| Amortization | 10,149 | — | 10,149 |
| Deferred income taxes | (31,735) | 2,084 | (29,651) |
| Equity-based compensation expense | 14,959 | — | 14,959 |
| Asset impairment and inventory write-down | 29,176 | — | 29,176 |
| Gain on sale of buildings | (979) | — | (979) |
| Other | 6,512 | (229) | 6,283 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | 23,262 | 12,700 | 35,962 |
| Unbilled receivables | 2,856 | (53,330) | (50,474) |
| Inventories | (126,978) | (4,352) | (131,330) |
| Accounts payable | 26,446 | — | 26,446 |
| Contract advances and progress billings | (84,296) | 42,579 | (41,717) |
| Accrued expenses | 26,493 | (18,593) | 7,900 |
| Accrued income taxes | 16,219 | (1,717) | 14,502 |
| Net pension and post retirement liabilities | 11,791 | — | 11,791 |
| Other assets and liabilities | (11,708) | 11,889 | 181 |
| Net cash provided (used) by operating activities | 202,344 | (4,482) | 197,862 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Acquisitions of businesses, net of cash acquired | (5,911) | — | (5,911) |
| Purchase of property, plant and equipment | (156,018) | 4,023 | (151,995) |
| Net proceeds from businesses sold | 1,627 | — | 1,627 |
| Net proceeds from buildings sold | 1,453 | — | 1,453 |
| Other investing transactions | (766) | — | (766) |
| Net cash provided (used) by investing activities | (159,615) | 4,023 | (155,592) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 1,038,500 | — | 1,038,500 |
| Payments on revolving lines of credit | (1,029,500) | — | (1,029,500) |
| Payments on finance lease obligations | (6,496) | 459 | (6,037) |
| Payment of dividends | (35,476) | — | (35,476) |
| Proceeds from sale of treasury stock | 15,685 | — | 15,685 |
| Purchase of outstanding shares for treasury | (36,738) | — | (36,738) |
| Proceeds from sale of stock held by SECT | 28,202 | — | 28,202 |
| Purchase of stock held by SECT | (22,837) | — | (22,837) |
| Net cash provided (used) by financing activities | (48,660) | 459 | (48,201) |
| Effect of exchange rate changes on cash | 1,324 | — | 1,324 |
| Increase (decrease) in cash, cash equivalents and restricted cash | (4,607) | — | (4,607) |
| Cash, cash equivalents and restricted cash at beginning of year | 69,144 | — | 69,144 |
| Cash, cash equivalents and restricted cash at end of year | $64,537 | $— | $64,537 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Interest paid | $61,164 | $4,218 | $65,382 |
| Income taxes paid, net of refunds | 78,482 | — | 78,482 |
| Treasury shares issued as compensation | 5,323 | — | 5,323 |
| Assets acquired through lease financing | 45,086 | (5,703) | 39,383 |
| Consolidated Condensed Statement of Earnings | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised |
| Net sales | $910,315 | $(2,433) | $907,882 |
| Cost of sales | 668,040 | (5,236) | 662,804 |
| Inventory write-down | — | — | — |
| Gross profit | 242,275 | 2,803 | 245,078 |
| Research and development | 23,605 | — | 23,605 |
| Selling, general and administrative | 127,781 | 356 | 128,137 |
| Interest | 17,002 | (754) | 16,248 |
| Restructuring | 3,784 | — | 3,784 |
| Other | 1,524 | (2,655) | (1,131) |
| Earnings before income taxes | 68,579 | 5,856 | 74,435 |
| Income taxes | 15,466 | 1,443 | 16,909 |
| Net earnings | $53,113 | $4,413 | $57,526 |
| Net earnings per share | |||
| Basic | $1.66 | $0.14 | $1.80 |
| Diluted | $1.64 | $0.14 | $1.78 |
| Consolidated Condensed Statement of Comprehensive Income | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| Net earnings | $53,113 | $4,413 | $57,526 |
| Other comprehensive income (loss) ("OCI"), net of tax: | |||
| Foreign currency translation adjustment | (41,696) | 100 | (41,596) |
| Retirement liability adjustment | 3,092 | (941) | 2,151 |
| Change in accumulated gain (loss) on derivatives | 262 | — | 262 |
| Other comprehensive income (loss), net of tax | (38,342) | (841) | (39,183) |
| Comprehensive income | $14,771 | $3,572 | $18,343 |
| Consolidated Condensed Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $73,448 | $— | $73,448 |
| Restricted cash | 360 | — | 360 |
| Receivables, net | 472,310 | — | 472,310 |
| Unbilled receivables | 735,759 | (13,375) | 722,384 |
| Inventories, net | 886,088 | (1,260) | 884,828 |
| Prepaid expenses and other current assets | 77,783 | — | 77,783 |
| Total current assets | 2,245,748 | (14,635) | 2,231,113 |
| Property, plant and equipment, net | 934,087 | — | 934,087 |
| Operating lease right-of-use assets | 56,744 | — | 56,744 |
| Goodwill | 818,503 | — | 818,503 |
| Intangible assets, net | 59,469 | — | 59,469 |
| Deferred income taxes | 24,219 | 3,471 | 27,690 |
| Other assets | 54,242 | — | 54,242 |
| Total assets | $4,193,012 | $(11,164) | $4,181,848 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $267,054 | $900 | $267,954 |
| Accrued compensation | 68,366 | — | 68,366 |
| Contract advances and progress billings | 293,550 | (390) | 293,160 |
| Accrued liabilities and other | 284,849 | 16,614 | 301,463 |
| Total current liabilities | 913,819 | 17,124 | 930,943 |
| Long-term debt, excluding current installments | 1,104,151 | — | 1,104,151 |
| Long-term pension and retirement obligations | 162,222 | — | 162,222 |
| Deferred income taxes | 26,080 | (44) | 26,036 |
| Other long-term liabilities | 171,962 | — | 171,962 |
| Total liabilities | 2,378,234 | 17,080 | 2,395,314 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,844 | — | 43,844 |
| Common stock - Class B | 7,436 | — | 7,436 |
| Additional paid-in capital | 777,060 | — | 777,060 |
| Retained earnings | 2,712,875 | (28,360) | 2,684,515 |
| Treasury shares | (1,141,242) | — | (1,141,242) |
| Stock Employee Compensation Trust | (186,219) | — | (186,219) |
| Supplemental Retirement Plan Trust | (156,865) | — | (156,865) |
| Accumulated other comprehensive loss | (242,111) | 116 | (241,995) |
| Total shareholders’ equity | 1,814,778 | (28,244) | 1,786,534 |
| Total liabilities and shareholders’ equity | $4,193,012 | $(11,164) | $4,181,848 |
| Consolidated Condensed Statement of Shareholders' Equity | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| COMMON STOCK | |||
| Beginning and end of year | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | |||
| Beginning of year | 784,509 | — | 784,509 |
| Issuance of treasury shares | 2,413 | — | 2,413 |
| Equity-based compensation expense | 3,346 | — | 3,346 |
| Adjustment to market - SECT and SERP | (13,208) | — | (13,208) |
| End of year | 777,060 | — | 777,060 |
| RETAINED EARNINGS | |||
| Beginning of year | 2,668,723 | (32,773) | 2,635,950 |
| Net earnings | 53,113 | 4,413 | 57,526 |
| Dividends | (8,961) | — | (8,961) |
| End of year | 2,712,875 | (28,360) | 2,684,515 |
| TREASURY SHARES AT COST | |||
| Beginning of year | (1,082,240) | — | (1,082,240) |
| Class A and B shares issued related to compensation | 773 | — | 773 |
| Class A and B shares purchased | (59,775) | — | (59,775) |
| End of year | (1,141,242) | — | (1,141,242) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | |||
| Beginning of year | (194,049) | — | (194,049) |
| Issuance of shares | 9,665 | — | 9,665 |
| Purchase of shares | (8,087) | — | (8,087) |
| Adjustment to market | 6,252 | — | 6,252 |
| End of year | (186,219) | — | (186,219) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | |||
| Beginning of year | (163,821) | — | (163,821) |
| Adjustment to market | 6,956 | — | 6,956 |
| End of year | (156,865) | — | (156,865) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | |||
| Beginning of year | (203,769) | 957 | (202,812) |
| Other comprehensive income (loss) | (38,342) | (841) | (39,183) |
| End of year | (242,111) | 116 | (241,995) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,814,778 | $(28,244) | $1,786,534 |
| Consolidated Condensed Statement of Cash Flows | |||
|---|---|---|---|
| Three Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $53,113 | $4,413 | $57,526 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 23,478 | (1,049) | 22,429 |
| Amortization | 2,323 | — | 2,323 |
| Deferred income taxes | (3,577) | (684) | (4,261) |
| Equity-based compensation expense | 4,325 | — | 4,325 |
| Other | 2,708 | (1,307) | 1,401 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | (63,037) | — | (63,037) |
| Unbilled receivables | (31,073) | (5,067) | (36,140) |
| Inventories | (48,711) | 99 | (48,612) |
| Accounts payable | (22,973) | — | (22,973) |
| Contract advances and progress billings | (1,314) | (2,729) | (4,043) |
| Accrued expenses | (29,372) | 2,071 | (27,301) |
| Accrued income taxes | (9,698) | 3,046 | (6,652) |
| Net pension and post retirement liabilities | 1,555 | (919) | 636 |
| Other assets and liabilities | (10,031) | 1,500 | (8,531) |
| Net cash provided (used) by operating activities | (132,284) | (626) | (132,910) |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Purchase of property, plant and equipment | (32,778) | — | (32,778) |
| Net proceeds from businesses sold | 13,487 | — | 13,487 |
| Other investing transactions | 169 | — | 169 |
| Net cash provided (used) by investing activities | (19,122) | — | (19,122) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 426,500 | — | 426,500 |
| Payments on revolving lines of credit | (197,000) | — | (197,000) |
| Payments on finance lease obligations | (2,745) | 626 | (2,119) |
| Payment of dividends | (8,961) | — | (8,961) |
| Purchase of outstanding shares for treasury | (55,692) | — | (55,692) |
| Proceeds from sale of stock held by SECT | 9,665 | — | 9,665 |
| Purchase of stock held by SECT | (8,087) | — | (8,087) |
| Other financing transactions | (439) | — | (439) |
| Net cash provided (used) by financing activities | 163,241 | 626 | 163,867 |
| Effect of exchange rate changes on cash | (2,564) | — | (2,564) |
| Increase (decrease) in cash, cash equivalents and restricted cash | 9,271 | — | 9,271 |
| Cash, cash equivalents and restricted cash at beginning of year | 64,537 | — | 64,537 |
| Cash, cash equivalents and restricted cash at end of year | $73,808 | $— | $73,808 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Treasury shares issued as compensation | $3,186 | $— | $3,186 |
| Assets acquired through lease financing | 18,862 | (1,690) | 17,172 |
| Consolidated Condensed Statement of Earnings | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Six Months Ended | ||||||
| March 29, 2025 | March 29, 2025 | |||||
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net sales | $934,840 | $(818) | $934,022 | $1,845,155 | $(3,251) | $1,841,904 |
| Cost of sales | 676,648 | (1,393) | 675,255 | 1,344,688 | (6,629) | 1,338,059 |
| Inventory write-down | 2,149 | — | 2,149 | 2,149 | — | 2,149 |
| Gross profit | 256,043 | 575 | 256,618 | 498,318 | 3,378 | 501,696 |
| Research and development | 24,481 | — | 24,481 | 48,086 | — | 48,086 |
| Selling, general and administrative | 133,102 | 830 | 133,932 | 260,883 | 1,186 | 262,069 |
| Interest | 19,548 | — | 19,548 | 36,550 | (754) | 35,796 |
| Restructuring | 2,425 | — | 2,425 | 6,209 | — | 6,209 |
| Other | 2,908 | 1,266 | 4,174 | 4,432 | (1,389) | 3,043 |
| Earnings before income taxes | 73,579 | (1,521) | 72,058 | 142,158 | 4,335 | 146,493 |
| Income taxes | 17,825 | (377) | 17,448 | 33,291 | 1,066 | 34,357 |
| Net earnings | $55,754 | $(1,144) | $54,610 | $108,867 | $3,269 | $112,136 |
| Net earnings per share | ||||||
| Basic | $1.77 | $(0.04) | $1.73 | $3.43 | $0.10 | $3.53 |
| Diluted | $1.75 | $(0.04) | $1.71 | $3.38 | $0.10 | $3.48 |
| Consolidated Condensed Statement of Comprehensive Income | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Six Months Ended | ||||||
| March 29, 2025 | March 29, 2025 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net earnings | $55,754 | $(1,144) | $54,610 | $108,867 | $3,269 | $112,136 |
| Other comprehensive income (loss) ("OCI"), net of tax: | ||||||
| Foreign currency translation adjustment | 22,988 | 11 | 22,999 | (18,708) | 111 | (18,597) |
| Retirement liability adjustment | 1,724 | — | 1,724 | 4,816 | (941) | 3,875 |
| Change in accumulated gain (loss) on derivatives | 400 | — | 400 | 662 | — | 662 |
| Other comprehensive income (loss), net of tax | 25,112 | 11 | 25,123 | (13,230) | (830) | (14,060) |
| Comprehensive income | $80,866 | $(1,133) | $79,733 | $95,637 | $2,439 | $98,076 |
| Consolidated Condensed Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $62,124 | $— | $62,124 |
| Restricted cash | 602 | — | 602 |
| Receivables, net | 537,179 | — | 537,179 |
| Unbilled receivables | 733,762 | (14,193) | 719,569 |
| Inventories, net | 902,551 | (1,330) | 901,221 |
| Prepaid expenses and other current assets | 95,554 | — | 95,554 |
| Total current assets | 2,331,772 | (15,523) | 2,316,249 |
| Property, plant and equipment, net | 960,015 | — | 960,015 |
| Operating lease right-of-use assets | 55,354 | — | 55,354 |
| Goodwill | 825,415 | — | 825,415 |
| Intangible assets, net | 57,915 | — | 57,915 |
| Deferred income taxes | 31,638 | 3,323 | 34,961 |
| Other assets | 57,146 | — | 57,146 |
| Total assets | $4,319,255 | $(12,200) | $4,307,055 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $293,052 | $900 | $293,952 |
| Accrued compensation | 69,411 | — | 69,411 |
| Contract advances and progress billings | 306,772 | 868 | 307,640 |
| Accrued liabilities and other | 282,180 | 15,457 | 297,637 |
| Total current liabilities | 951,415 | 17,225 | 968,640 |
| Long-term debt, excluding current installments | 1,165,662 | — | 1,165,662 |
| Long-term pension and retirement obligations | 172,395 | — | 172,395 |
| Deferred income taxes | 26,384 | (48) | 26,336 |
| Other long-term liabilities | 167,982 | — | 167,982 |
| Total liabilities | 2,483,838 | 17,177 | 2,501,015 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,852 | — | 43,852 |
| Common stock - Class B | 7,428 | — | 7,428 |
| Additional paid-in capital | 750,119 | — | 750,119 |
| Retained earnings | 2,759,484 | (29,504) | 2,729,980 |
| Treasury shares | (1,204,032) | — | (1,204,032) |
| Stock Employee Compensation Trust | (162,945) | — | (162,945) |
| Supplemental Retirement Plan Trust | (141,490) | — | (141,490) |
| Accumulated other comprehensive loss | (216,999) | 127 | (216,872) |
| Total shareholders’ equity | 1,835,417 | (29,377) | 1,806,040 |
| Total liabilities and shareholders’ equity | $4,319,255 | $(12,200) | $4,307,055 |
| Consolidated Condensed Statement of Shareholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Six Months Ended | ||||||
| March 29, 2025 | March 29, 2025 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| COMMON STOCK | ||||||
| Beginning and end of year | $51,280 | $— | $51,280 | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | ||||||
| Beginning of year | 777,060 | — | 777,060 | 784,509 | — | 784,509 |
| Issuance of treasury shares | 6,137 | — | 6,137 | 8,550 | — | 8,550 |
| Equity-based compensation expense | 2,668 | — | 2,668 | 6,014 | — | 6,014 |
| Adjustment to market - SECT and SERP | (35,746) | — | (35,746) | (48,954) | — | (48,954) |
| End of year | 750,119 | — | 750,119 | 750,119 | — | 750,119 |
| RETAINED EARNINGS | ||||||
| Beginning of year | 2,712,875 | (28,360) | 2,684,515 | 2,668,723 | (32,773) | 2,635,950 |
| Net earnings | 55,754 | (1,144) | 54,610 | 108,867 | 3,269 | 112,136 |
| Dividends | (9,145) | — | (9,145) | (18,106) | — | (18,106) |
| End of year | 2,759,484 | (29,504) | 2,729,980 | 2,759,484 | (29,504) | 2,729,980 |
| TREASURY SHARES AT COST | ||||||
| Beginning of year | (1,141,242) | — | (1,141,242) | (1,082,240) | — | (1,082,240) |
| Class A and B shares issued related to compensation | 4,790 | — | 4,790 | 5,563 | — | 5,563 |
| Class A and B shares purchased | (67,580) | — | (67,580) | (127,355) | — | (127,355) |
| End of year | (1,204,032) | — | (1,204,032) | (1,204,032) | — | (1,204,032) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | ||||||
| Beginning of year | (186,219) | — | (186,219) | (194,049) | — | (194,049) |
| Issuance of shares | 9,624 | — | 9,624 | 19,289 | — | 19,289 |
| Purchase of shares | (6,721) | — | (6,721) | (14,808) | — | (14,808) |
| Adjustment to market | 20,371 | — | 20,371 | 26,623 | — | 26,623 |
| End of year | (162,945) | — | (162,945) | (162,945) | — | (162,945) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | ||||||
| Beginning of year | (156,865) | — | (156,865) | (163,821) | — | (163,821) |
| Adjustment to market | 15,375 | — | 15,375 | 22,331 | — | 22,331 |
| End of year | (141,490) | — | (141,490) | (141,490) | — | (141,490) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | ||||||
| Beginning of year | (242,111) | 116 | (241,995) | (203,769) | 957 | (202,812) |
| Other comprehensive income (loss) | 25,112 | 11 | 25,123 | (13,230) | (830) | (14,060) |
| End of year | (216,999) | 127 | (216,872) | (216,999) | 127 | (216,872) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,835,417 | $(29,377) | $1,806,040 | $1,835,417 | $(29,377) | $1,806,040 |
| Consolidated Statement of Cash Flows | |||
|---|---|---|---|
| Six Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $108,867 | $3,269 | $112,136 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 45,822 | (1,043) | 44,779 |
| Amortization | 4,629 | — | 4,629 |
| Deferred income taxes | (12,252) | (572) | (12,824) |
| Equity-based compensation expense | 8,020 | — | 8,020 |
| Other | 2,997 | (706) | 2,291 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | (123,555) | — | (123,555) |
| Unbilled receivables | (26,967) | (4,249) | (31,216) |
| Inventories | (54,209) | 169 | (54,040) |
| Accounts payable | 1,975 | — | 1,975 |
| Contract advances and progress billings | 9,964 | (1,463) | 8,501 |
| Accrued expenses | (30,966) | 1,443 | (29,523) |
| Accrued income taxes | (24,986) | 2,557 | (22,429) |
| Net pension and post retirement liabilities | 12,986 | (919) | 12,067 |
| Other assets and liabilities | (15,187) | 1,482 | (13,705) |
| Net cash provided (used) by operating activities | (92,862) | (32) | (92,894) |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Purchase of property, plant and equipment | (70,382) | — | (70,382) |
| Net proceeds from businesses sold | 13,487 | — | 13,487 |
| Other investing transactions | (2,062) | — | (2,062) |
| Net cash provided (used) by investing activities | (58,957) | — | (58,957) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 752,500 | — | 752,500 |
| Payments on revolving lines of credit | (462,000) | — | (462,000) |
| Payments on finance lease obligations | (4,501) | 32 | (4,469) |
| Payment of dividends | (18,106) | — | (18,106) |
| Proceeds from sale of treasury stock | 7,825 | — | 7,825 |
| Purchase of outstanding shares for treasury | (126,425) | — | (126,425) |
| Proceeds from sale of stock held by SECT | 19,289 | — | 19,289 |
| Purchase of stock held by SECT | (14,808) | — | (14,808) |
| Other financing transactions | (1,457) | — | (1,457) |
| Net cash provided (used) by financing activities | 152,317 | 32 | 152,349 |
| Effect of exchange rate changes on cash | (2,309) | — | (2,309) |
| Increase (decrease) in cash, cash equivalents and restricted cash | (1,811) | — | (1,811) |
| Cash, cash equivalents and restricted cash at beginning of year | 64,537 | — | 64,537 |
| Cash, cash equivalents and restricted cash at end of year | $62,726 | $— | $62,726 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Treasury shares issued as compensation | $6,288 | $— | $6,288 |
| Assets acquired through lease financing | 25,094 | (1,095) | 23,999 |
| Consolidated Condensed Statement of Earnings | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Nine Months Ended | ||||||
| June 28, 2025 | June 28, 2025 | |||||
| (dollars in thousands, except share and per share data) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net sales | $971,363 | $(1,781) | $969,582 | $2,816,518 | $(5,032) | $2,811,486 |
| Cost of sales | 699,685 | (2,772) | 696,913 | 2,044,373 | (9,401) | 2,034,972 |
| Inventory write-down | 5,839 | — | 5,839 | 7,988 | — | 7,988 |
| Gross profit | 265,839 | 991 | 266,830 | 764,157 | 4,369 | 768,526 |
| Research and development | 21,906 | — | 21,906 | 69,992 | — | 69,992 |
| Selling, general and administrative | 138,801 | 947 | 139,748 | 399,684 | 2,133 | 401,817 |
| Interest | 17,790 | — | 17,790 | 54,340 | (754) | 53,586 |
| Asset impairment and fair value adjustment | 3,000 | — | 3,000 | 3,000 | — | 3,000 |
| Restructuring | 2,850 | — | 2,850 | 9,059 | — | 9,059 |
| Other | 3,510 | 1,673 | 5,183 | 7,942 | 284 | 8,226 |
| Earnings before income taxes | 77,982 | (1,629) | 76,353 | 220,140 | 2,706 | 222,846 |
| Income taxes | 18,275 | (408) | 17,867 | 51,566 | 658 | 52,224 |
| Net earnings | $59,707 | $(1,221) | $58,486 | $168,574 | $2,048 | $170,622 |
| Net earnings per share | ||||||
| Basic | $1.89 | $(0.04) | $1.86 | $5.32 | $0.06 | $5.38 |
| Diluted | $1.87 | $(0.04) | $1.83 | $5.25 | $0.06 | $5.32 |
| Consolidated Condensed Statement of Comprehensive Income | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Nine Months Ended | ||||||
| June 28, 2025 | June 28, 2025 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| Net earnings | $59,707 | $(1,221) | $58,486 | $168,574 | $2,048 | $170,622 |
| Other comprehensive income (loss) ("OCI"), net of tax: | ||||||
| Foreign currency translation adjustment | 53,380 | (57) | 53,323 | 34,672 | 54 | 34,726 |
| Retirement liability adjustment | 1,112 | — | 1,112 | 5,928 | (941) | 4,987 |
| Change in accumulated gain (loss) on derivatives | 504 | — | 504 | 1,166 | — | 1,166 |
| Other comprehensive income (loss), net of tax | 54,996 | (57) | 54,939 | 41,766 | (887) | 40,879 |
| Comprehensive income | $114,703 | $(1,278) | $113,425 | $210,340 | $1,161 | $211,501 |
| Consolidated Condensed Balance Sheet | |||
|---|---|---|---|
| (dollars in thousands) | As Reported | Revisions | As Revised |
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | $58,191 | $— | $58,191 |
| Restricted cash | 823 | — | 823 |
| Receivables, net | 529,753 | — | 529,753 |
| Unbilled receivables | 734,976 | (15,974) | 719,002 |
| Inventories, net | 924,682 | — | 924,682 |
| Prepaid expenses and other current assets | 153,479 | — | 153,479 |
| Total current assets | 2,401,904 | (15,974) | 2,385,930 |
| Property, plant and equipment, net | 988,125 | — | 988,125 |
| Operating lease right-of-use assets | 52,877 | — | 52,877 |
| Goodwill | 802,089 | — | 802,089 |
| Intangible assets, net | 57,182 | — | 57,182 |
| Deferred income taxes | 37,701 | 3,420 | 41,121 |
| Other assets | 56,696 | — | 56,696 |
| Total assets | $4,396,574 | $(12,554) | $4,384,020 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
| Current liabilities | |||
| Accounts payable | $289,160 | $— | $289,160 |
| Accrued compensation | 98,292 | — | 98,292 |
| Contract advances and progress billings | 298,648 | 2,622 | 301,270 |
| Accrued liabilities and other | 302,514 | 15,529 | 318,043 |
| Total current liabilities | 988,614 | 18,151 | 1,006,765 |
| Long-term debt, excluding current installments | 1,081,674 | — | 1,081,674 |
| Long-term pension and retirement obligations | 177,688 | — | 177,688 |
| Deferred income taxes | 27,664 | (50) | 27,614 |
| Other long-term liabilities | 177,233 | — | 177,233 |
| Total liabilities | 2,452,873 | 18,101 | 2,470,974 |
| Shareholders’ equity | |||
| Common stock - Class A | 43,864 | — | 43,864 |
| Common stock - Class B | 7,416 | — | 7,416 |
| Additional paid-in capital | 769,935 | — | 769,935 |
| Retained earnings | 2,810,050 | (30,725) | 2,779,325 |
| Treasury shares | (1,205,305) | — | (1,205,305) |
| Stock Employee Compensation Trust | (173,214) | — | (173,214) |
| Supplemental Retirement Plan Trust | (147,042) | — | (147,042) |
| Accumulated other comprehensive loss | (162,003) | 70 | (161,933) |
| Total shareholders’ equity | 1,943,701 | (30,655) | 1,913,046 |
| Total liabilities and shareholders’ equity | $4,396,574 | $(12,554) | $4,384,020 |
| Consolidated Condensed Statement of Shareholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended · Nine Months Ended | ||||||
| June 28, 2025 | June 28, 2025 | |||||
| (dollars in thousands) | As Reported | Revisions | As Revised | As Reported | Revisions | As Revised |
| COMMON STOCK | ||||||
| Beginning and end of year | $51,280 | $— | $51,280 | $51,280 | $— | $51,280 |
| ADDITIONAL PAID-IN CAPITAL | ||||||
| Beginning of year | 750,119 | — | 750,119 | 784,509 | — | 784,509 |
| Issuance of treasury shares | 3,035 | — | 3,035 | 11,585 | — | 11,585 |
| Equity-based compensation expense | 3,659 | — | 3,659 | 9,673 | — | 9,673 |
| Adjustment to market - SECT and SERP | 13,122 | — | 13,122 | (35,832) | — | (35,832) |
| End of year | 769,935 | — | 769,935 | 769,935 | — | 769,935 |
| RETAINED EARNINGS | ||||||
| Beginning of year | 2,759,484 | (29,504) | 2,729,980 | 2,668,723 | (32,773) | 2,635,950 |
| Net earnings | 59,707 | (1,221) | 58,486 | 168,574 | 2,048 | 170,622 |
| Dividends | (9,141) | — | (9,141) | (27,247) | — | (27,247) |
| End of year | 2,810,050 | (30,725) | 2,779,325 | 2,810,050 | (30,725) | 2,779,325 |
| TREASURY SHARES AT COST | ||||||
| Beginning of year | (1,204,032) | — | (1,204,032) | (1,082,240) | — | (1,082,240) |
| Class A and B shares issued related to compensation | 110 | — | 110 | 5,673 | — | 5,673 |
| Class A and B shares purchased | (1,383) | — | (1,383) | (128,738) | — | (128,738) |
| End of year | (1,205,305) | — | (1,205,305) | (1,205,305) | — | (1,205,305) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | ||||||
| Beginning of year | (162,945) | — | (162,945) | (194,049) | — | (194,049) |
| Issuance of shares | 998 | — | 998 | 20,287 | — | 20,287 |
| Purchase of shares | (3,697) | — | (3,697) | (18,505) | — | (18,505) |
| Adjustment to market | (7,570) | — | (7,570) | 19,053 | — | 19,053 |
| End of year | (173,214) | — | (173,214) | (173,214) | — | (173,214) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | ||||||
| Beginning of year | (141,490) | — | (141,490) | (163,821) | — | (163,821) |
| Adjustment to market | (5,552) | — | (5,552) | 16,779 | — | 16,779 |
| End of year | (147,042) | — | (147,042) | (147,042) | — | (147,042) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS | ||||||
| Beginning of year | (216,999) | 127 | (216,872) | (203,769) | 957 | (202,812) |
| Other comprehensive income (loss) | 54,996 | (57) | 54,939 | 41,766 | (887) | 40,879 |
| End of year | (162,003) | 70 | (161,933) | (162,003) | 70 | (161,933) |
| TOTAL SHAREHOLDERS’ EQUITY | $1,943,701 | $(30,655) | $1,913,046 | $1,943,701 | $(30,655) | $1,913,046 |
| Consolidated Condensed Statement of Cash Flows | |||
|---|---|---|---|
| Nine Months Ended | |||
| (dollars in thousands) | As Reported | Revisions | As Revised |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net earnings | $168,574 | $2,048 | $170,622 |
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||
| Depreciation | 69,292 | (1,040) | 68,252 |
| Amortization | 6,996 | — | 6,996 |
| Deferred income taxes | (18,645) | (997) | (19,642) |
| Equity-based compensation expense | 12,669 | — | 12,669 |
| Asset impairment and inventory write-down | 10,988 | — | 10,988 |
| Other | 4,399 | (751) | 3,648 |
| Changes in assets and liabilities providing (using) cash: | |||
| Receivables | (105,346) | — | (105,346) |
| Unbilled receivables | (35,174) | (2,468) | (37,642) |
| Inventories | (64,095) | (1,161) | (65,256) |
| Accounts payable | (3,301) | (900) | (4,201) |
| Contract advances and progress billings | 8,798 | 211 | 9,009 |
| Accrued expenses | (6,645) | 1,849 | (4,796) |
| Accrued income taxes | (22,669) | 2,574 | (20,095) |
| Net pension and post retirement liabilities | 15,563 | (919) | 14,644 |
| Other assets and liabilities | (8,941) | 1,488 | (7,453) |
| Net cash provided (used) by operating activities | 32,463 | (66) | 32,397 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Purchase of property, plant and equipment | (103,041) | — | (103,041) |
| Net proceeds from businesses sold | 13,487 | — | 13,487 |
| Other investing transactions | (2,844) | — | (2,844) |
| Net cash provided (used) by investing activities | (92,398) | — | (92,398) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from revolving lines of credit | 957,500 | — | 957,500 |
| Payments on revolving lines of credit | (1,001,500) | — | (1,001,500) |
| Proceeds from long-term debt | 250,000 | — | 250,000 |
| Payments on finance lease obligations | (7,194) | 66 | (7,128) |
| Payment of dividends | (27,247) | — | (27,247) |
| Proceeds from sale of treasury stock | 10,970 | — | 10,970 |
| Purchase of outstanding shares for treasury | (127,808) | — | (127,808) |
| Proceeds from sale of stock held by SECT | 20,287 | — | 20,287 |
| Purchase of stock held by SECT | (18,505) | — | (18,505) |
| Other financing transactions | (1,600) | — | (1,600) |
| Net cash provided (used) by financing activities | 54,903 | 66 | 54,969 |
| Effect of exchange rate changes on cash | (491) | — | (491) |
| Increase (decrease) in cash, cash equivalents and restricted cash | (5,523) | — | (5,523) |
| Cash, cash equivalents and restricted cash at beginning of year | 64,537 | — | 64,537 |
| Cash, cash equivalents and restricted cash at end of year | $59,014 | $— | $59,014 |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Treasury shares issued as compensation | $6,288 | $— | $6,288 |
| Assets acquired through lease financing | 36,787 | (1,130) | 35,657 |
To the Shareholders and the Board of Directors of Moog Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Moog Inc. (the Company) as of September 27, 2025 and September 28, 2024, the related consolidated statements of earnings, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended September 27, 2025, and the related notes and financial statement schedules listed in the Index at Item 15(2) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at September 27, 2025 and September 28, 2024, and the results of its operations and its cash flows for each of the three years in the period ended September 27, 2025, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of September 27, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated November 26, 2025 expressed an adverse opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosure to which it relates.
| Estimated costs at completion used to recognize revenue for select long-term production contracts | |
| Description of the Matter | As discussed in Note 2 to the consolidated financial statements, the Company recognizes revenue over time for U.S. Government contracts and certain large commercial contracts. Revenue is recognized for these contracts using the cost-to-cost method of accounting as work progresses toward completion as determined by the ratio of cumulative costs incurred to date to estimated total contract costs at completion, multiplied by the total estimated contract revenue, less cumulative revenue recognized in prior periods. The Company regularly reviews the progress and performance on its ongoing contracts and adjusts the estimated costs at completion, as necessary. A change in these estimates could have a significant impact on the revenue recognition for select contracts with a higher magnitude and longer term of duration. For a select group of long-term production contracts, auditing management’s estimates of the total costs at completion required a high degree of subjectivity and audit effort due to the judgment involved in evaluating the assumptions related to estimated material and labor costs to be incurred over the duration of these select contracts. |
|---|---|
| How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of the control over management’s review of estimated total contract costs at completion for these select long-term production contracts, including the data used in determining the underlying assumptions described above. To test the accuracy of the Company’s estimated total contract costs at completion for the select long-term production contracts, our audit procedures included, among others, inquiries of key personnel involved in developing the estimates, inspection of historical program costs to support the future estimated costs, sensitivity analyses to evaluate changes in the revenue recognized that would result from changes in the estimated total contract costs at completion, and/or analytical procedures comparing profit rates to similar contracts. We assessed the historical accuracy of management’s estimated total contract costs at completion. We also tested the completeness and accuracy of the underlying data back to source documents and contracts. |
/s/Ernst & Young LLP
We have served as the Company’s auditor since 2003.
Buffalo, New York
November 26, 2025
MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of September 27, 2025 based upon the framework in Internal Control - Integrated Framework (2013) by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management concluded that our internal control over financial reporting was not effective as of September 27, 2025, due to the material weakness described below.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. Because the control deficiency described below could have resulted in a material misstatement of its annual or interim financial statements, the Company determined that this deficiency constitutes a material weakness.
Management identified a material weakness in the design and operation of its controls over a distinct group of long-term aftermarket service revenue contracts in the Company’s Commercial Aircraft segment. Specifically, management did not have adequate controls to address the completeness and accuracy of key inputs utilized in recognizing revenue and contract losses for these contracts.
Notwithstanding such material weakness in internal control over financial reporting, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s Consolidated Financial Statements included in this Annual Report on Form 10-K present fairly, in all material respects, the Company’s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP.
We completed one acquisition in 2025, which was excluded from our management's report on internal controls over financial reporting as of September 27, 2025. On July 1, 2025, we acquired COTSWORKS, Inc. This acquisition in included in our 2025 consolidated financial statements and constit uted $67.5 million and $61.2 million of total and net assets, respectively, as of September 27, 2025 and $4.7 million and $2.2 million of revenues and net loss, respectively, for the year then ended.
Ernst & Young LLP, independent registered public accounting firm, has audited our consolidated financial statements included in this Annual Report on Form 10-K and, as part of their audit, has issued their report, included herein, on the effectiveness of our internal control over financial reporting.
/s/ PAT ROCHE
Pat Roche
Chief Executive Officer
(Principal Executive Officer)
/s/ JENNIFER WALTER
Jennifer Walter
Chief Financial Officer
(Principal Financial Officer)
To the Shareholders and the Board of Directors of Moog Inc.
Opinion on Internal Control over Financial Reporting
We have audited Moog Inc.’s internal control over financial reporting as of September 27, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, because of the effect of the material weakness described below on the achievement of the objectives of the control criteria, Moog Inc. (the Company) has not maintained effective internal control over financial reporting as of September 27, 2025, based on the COSO criteria.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management’s assessment.
Management has identified a material weakness in the design and operation of its controls over long-term aftermarket service revenue contracts in the Company’s Commercial Aircraft segment. Specifically, management did not have adequate review controls to address the completeness and accuracy of key inputs utilized in recognizing revenue and contract losses for these contracts.
As indicated in the accompanying Management's Report on Internal Controls Over Financial Reporting, management's assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal control of COTSWORKS, Inc. which is included in the 2025 consolidated financial statements of the Company and constituted $67.5 million and $61.2 million of total and net assets, respectively, as of September 27, 2025 and $4.7 million and $2.2 million of revenues and net loss. respectively, for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal controls over financial reporting of COTSWORKS, Inc.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of September 27, 2025 and September 28, 2024, the related consolidated statements of earnings, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended September 27, 2025, and the related notes and schedule listed in the Index at Item 15(2). The material weakness was considered in determining the nature, timing and extent of audit tests applied in our audit of the 2025 consolidated financial statements, and this report does not affect our report dated November 26, 2025 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/Ernst & Young LLP
Buffalo, New York
November 26, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.